Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1050.Time spend outdoors in summer,46753,-0.0264490931005272,0.0586690037004027,-0.141440340353317,0.0885421541522622,0.652125677467063
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1060.Time spent outdoors in winter,44952,0.0519748106502328,0.0655741434656844,-0.0765505105425087,0.180500131842974,0.428016224719075
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1070.Time spent watching television (TV),47768,-0.0343520111525559,0.0586871737432691,-0.149378871689363,0.0806748493842515,0.558325538084222
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1080.Time spent using computer,44981,0.010310429907715,0.0584222810916781,-0.104197241031974,0.124818100847404,0.859918239719189
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1090.Time spent driving,41500,-0.0748859827733345,0.0677569974414129,-0.207689697758504,0.0579177322118348,0.269088477171804
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1160.Sleep duration,48428,0.0412328303533778,0.0518946919158685,-0.0604807658017245,0.14294642650848,0.426886205844489
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34602,0.0186234134715623,0.0115278167523543,-0.00397110736305205,0.0412179343061767,0.106256559709885
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34602,-0.00865800284683925,0.0110730532710602,-0.0303611872581172,0.0130451815644387,0.434308504827926
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34602,0.00563055957725696,0.0119704662374309,-0.0178315542481075,0.0290926734026214,0.638108983604495
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34602,-0.00869321748603559,0.0121209421413251,-0.0324502640830328,0.0150638291109616,0.473277715247561
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34602,0.0031126606792752,0.0121549217562432,-0.0207109859629616,0.0269363073215119,0.797897006078918
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34602,-0.0636174577827336,0.0315399551349433,-0.125435769847223,-0.0017991457182446,0.0437403059895837
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34602,-0.00145768870194917,0.0318088514780506,-0.0638030375989284,0.0608876601950301,0.963450219804194
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34602,0.00447847378827533,0.0214998513095406,-0.0376612347784242,0.0466181823549749,0.835000587298222
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34602,-0.0050974212122522,0.015339575876734,-0.0351629899306509,0.0249681475061465,0.739671673888867
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34602,-0.00571123227784682,0.00987870228631752,-0.0250734887590292,0.0136510242033355,0.563196454165648
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34602,0.00514008593699071,0.0149917392327809,-0.0242437229592599,0.0345238948332413,0.731716196384895
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34602,-0.0130632498558279,0.00803361566610968,-0.0288091365614028,0.00268263684974709,0.103992276901101
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34602,-0.00752092162346159,0.0103689399538655,-0.0278440439330379,0.0128022006861147,0.468279900588441
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34602,-0.0245581353990448,0.0148964238792038,-0.0537551262022843,0.00463885540419477,0.0992891943014813
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34602,-0.00835497418585651,0.0140363978822374,-0.0358663140350418,0.0191563656633288,0.551710403985095
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34602,-0.0212125764476445,0.021722715068141,-0.0637890979812009,0.0213639450859119,0.32885255564307
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34602,-0.0210824182852933,0.020820072921707,-0.061889761211839,0.0197249246412525,0.311296275415943
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34602,0.00827376046846317,0.0108203675710856,-0.0129341599708646,0.029481680907791,0.444515199647883
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34602,-0.00784611826590437,0.0103226495399128,-0.0280785113641334,0.0123862748323246,0.447235337620572
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34602,0.0215499903202335,0.0130802758827603,-0.00408735040997673,0.0471873310504437,0.0995097089132792
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120040.Fatigue severity over the past week,34609,-0.10497896880175,0.102291070929428,-0.305469467823429,0.0955115302199276,0.304806914867424
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120041.Waking unrefreshed severity over the past week,34607,-0.0867456824494502,0.101893353524575,-0.286456655357617,0.112965290458717,0.394619302676511
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120042.Cognitive symptoms severity over the past week,34607,-0.0962265327057587,0.108342932031881,-0.308578679488246,0.116125614076729,0.374490822994041
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120098.Mobility problems today,34611,0.0543636062825295,0.112469474105538,-0.166076562964325,0.274803775529385,0.628857410988979
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120099.Self-care problems today,34611,0.00931836730695229,0.173663096241608,-0.331061301326599,0.349698035940504,0.957209841584615
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120100.Problems doing usual activities,34611,0.0950687015484332,0.109587634468406,-0.119723062009643,0.30986046510651,0.385699420272897
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120101.Pain or discomfort today,34611,0.0347062977008786,0.101941071610626,-0.165098202655949,0.234510798057706,0.733527482696011
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120102.Anxiety or depression today,34611,-0.0556364317053674,0.128812339497946,-0.308108617121341,0.196835753710606,0.665817852736365
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120103.Scale to indicate how health is today,34593,-0.00288215301659624,0.00350720995302115,-0.00975628452451769,0.00399197849132522,0.411238727233666
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34589,-0.166257843267172,0.132078195595981,-0.425131106635295,0.0926154201009516,0.208163055090458
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34578,-0.0981400332222976,0.13794158840092,-0.368505546488101,0.172225480043505,0.4768295664675
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34593,0.0030986005298543,0.103111726097821,-0.199000382621875,0.205197583681584,0.97602756751093
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34594,-0.0596655690999428,0.105667897875561,-0.266774648936041,0.147443510736156,0.572334084687727
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34603,-0.0668378945635717,0.153143685728077,-0.366999518590603,0.233323729463459,0.662535591064602
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120109.Feeling bad about self over the last two weeks,34587,-0.0168704451994351,0.147775060736448,-0.306509564242873,0.272768673844003,0.909112828053741
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120110.Trouble concentrating over the last two weeks,34598,-0.168752029614205,0.14796636724936,-0.45876610942295,0.12126205019454,0.254138777682295
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34596,-0.55643181404824,0.209676815573664,-0.967398372572621,-0.14546525552386,0.00798337886152609
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34575,0.0393343609772265,0.301209262104924,-0.551035792748425,0.629704514702878,0.896105998892636
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32772,0.201578202567231,0.142891103061937,-0.0784883594341652,0.481644764568627,0.158416515677246
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46904,-0.0246049013734299,0.12867944007241,-0.276816603915354,0.227606801168494,0.84836261820472
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45436,-0.0312017553438044,0.0793916634778079,-0.186809415760308,0.124405905072699,0.694316903271631
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1289.Cooked vegetable intake,48047,-0.056890013251101,0.055521770153143,-0.165712682751261,0.0519326562490592,0.305544643667254
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47373,-0.0306746493401034,0.0579353239827803,-0.144227884346353,0.0828785856661459,0.596490304950434
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1309.Fresh fruit intake,47997,0.021288682410643,0.0562746657618159,-0.0890096624825161,0.131587027303802,0.705212328460863
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1319.Dried fruit intake,46978,0.0742801056178734,0.0569378163235505,-0.0373180143762856,0.185878225612032,0.19205177255103
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X134.Number of self-reported cancers,48607,-0.0282557928870202,0.0886252814815778,-0.201961344590913,0.145449758816872,0.749864040489028
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X135.Number of self-reported non-cancer illnesses,48608,0.0174230803135371,0.0563402363464566,-0.0930037829255178,0.127849943552592,0.757136541079493
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X136.Number of operations, self-reported",48608,-0.0659057248971721,0.0541944673520934,-0.172126880907275,0.040315431112931,0.223962789867478
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X137.Number of treatments or medications taken,48608,0.0286253312328304,0.0543681829679023,-0.077936307384258,0.135186969849919,0.598540697688789
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1438.Bread intake,48083,0.00282975084292131,0.00200353476975977,-0.00109717730580784,0.00675667899165045,0.157854811172802
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1458.Cereal intake,47799,-0.0602172453350356,0.0538923517582671,-0.165846254781239,0.0454117641111678,0.263854168696075
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1488.Tea intake,48007,-0.000205522566937353,0.00193473659046915,-0.00399760628425688,0.00358656115038217,0.91540284745513
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1498.Coffee intake,47173,0.0409068067059849,0.0539403713479182,-0.0648163211359347,0.146629934547905,0.448238928883197
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1528.Water intake,47069,-0.0420144872652042,0.0545224208676141,-0.148878432165728,0.0648494576353194,0.440959577809116
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1568.Average weekly red wine intake,42440,-0.0111403744192549,0.0643758341020364,-0.137317009259246,0.115036260420736,0.86261310587114
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42441,0.0827253091624924,0.0658502961551617,-0.0463412713016244,0.211791889626609,0.20904268534283
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1588.Average weekly beer plus cider intake,42481,-0.0999638902515564,0.0737396287914064,-0.244493562682713,0.0445657821796002,0.175238940005095
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1598.Average weekly spirits intake,42427,-0.133705505058072,0.0695302923280284,-0.269984878021007,0.00257386790486377,0.0545037392081566
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1608.Average weekly fortified wine intake,42469,-0.13408518219918,0.104479324780193,-0.338864658768358,0.0706942943699969,0.199386387714157
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1737.Childhood sunburn occasions,43338,-0.039496740232126,0.0665173300244893,-0.169870707080125,0.0908772266158729,0.552667959359604
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1807.Father's age at death,46849,3.08192787028988e-05,0.00187067203048258,-0.00363569790104295,0.00369733645844875,0.986855650992119
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1845.Mother's age,32072,-0.00513683811471967,0.00883470593273547,-0.0224528617428812,0.0121791855134418,0.560990493862859
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1873.Number of full brothers,48263,0.0104255698062597,0.0524177554737829,-0.0923132309223548,0.113164370534874,0.842347891837404
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1883.Number of full sisters,48267,0.0537654965062693,0.0525820170715642,-0.0492952569539964,0.156826249966535,0.3065538268448
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20015.Sitting height,48471,0.00478791985368956,0.00249793120674676,-0.000108025311534084,0.0096838650189132,0.0552839477411578
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20016.Fluid intelligence score,35623,-0.0707968337779626,0.0837597430554466,-0.234965930166638,0.0933722626107127,0.398010042367504
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20018.Prospective memory result,35908,0.10003734856173,0.0998901501633476,-0.0957473457584316,0.295822042881891,0.316633992687474
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35508,0.00461333749128953,0.00341061675512922,-0.00207147134876374,0.0112981463313428,0.176219024330959
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35493,0.00676309499342029,0.00342349170605845,5.30512495457332e-05,0.0134731387372948,0.0482554424538768
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20023.Mean time to correctly identify matches,48358,0.000503336841350731,0.00203959354101576,-0.00349426649904015,0.00450094018174162,0.805078876120765
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#1.Illnesses of father_Heart disease,45760,8.3703538545315e-05,0.00428348273060701,-0.00831192261344442,0.00847932969053505,0.984409764878373
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45398,-0.00776893688128923,0.00894676023665452,-0.0253045869451321,0.00976671318255362,0.385214539761411
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45362,0.0119327523524588,0.0122476030436987,-0.0120725496131906,0.0359380543181081,0.329925718821713
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#12.Illnesses of father_Severe depression,45374,-0.00231037358768368,0.0114304076323024,-0.0247139725469963,0.020093225371629,0.839821378004142
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45398,0.00752184223352668,0.00795539200453511,-0.00807072609536214,0.0231144105624155,0.344416544316286
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#2.Illnesses of father_Stroke,45536,-0.00141062583927015,0.00538352965859612,-0.0119623439701186,0.00914109229157824,0.793304542621167
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45496,-0.00727974889509894,0.0065518502365662,-0.0201213753587687,0.00556187756857081,0.266542476640943
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45403,-0.0144430622343745,0.00843061164046385,-0.0309670610496837,0.00208093658093461,0.0867005816269368
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45543,-0.000607387671253248,0.00579658515593041,-0.0119686945768769,0.0107539192343704,0.916548725475243
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45539,0.00322754305793577,0.00537253737504362,-0.00730263019714972,0.0137577163130213,0.548015928430721
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#9.Illnesses of father_Diabetes,45429,0.0081494923098108,0.00774950321552206,-0.00703953399261244,0.023338518612234,0.292991964735817
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46665,-0.00206678412773936,0.00465789870503416,-0.0111962655896063,0.0070626973341276,0.65725342945774
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46532,0.000548893651583546,0.00609640542306537,-0.0114000609776246,0.0124978482807917,0.928259947865537
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46457,0.0175764581001309,0.0135007006066434,-0.0088849150888903,0.044037831289152,0.192970577921674
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46476,-0.0071726652241457,0.00846036555493,-0.0237549817118085,0.00940965126351709,0.396563256691832
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#2.Illnesses of mother_Stroke,46615,0.000574819711482173,0.00508600716400067,-0.00939375432995913,0.0105433937529235,0.910016128896421
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46495,0.00279896233527112,0.00978956291474358,-0.0163885809776263,0.0219865056481685,0.774948255298864
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46481,0.00145677811212833,0.00828976979054382,-0.0147911706773375,0.0177047269015942,0.860506525223898
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46486,-0.0119284859186526,0.00728633188929512,-0.026209696421671,0.00235272458436585,0.101626856230206
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46529,-0.00598365555326444,0.00808054914448557,-0.0218215318764562,0.00985422076992727,0.459006021583147
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46651,0.0046985555134885,0.00452509482909604,-0.00417063035153974,0.0135677413785167,0.299129408560874
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46543,0.00926192365069987,0.00696226220726587,-0.00438411027554124,0.022907957576941,0.18343569234086
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43531,-0.01431598914793,0.00583389292416069,-0.0257504192792849,-0.00288155901657504,0.0141420931229851
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43372,-0.00915922629581108,0.0204257158287038,-0.0491936293200706,0.0308751767284484,0.653859548669832
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43366,0.00628683951695043,0.0217012473429616,-0.0362476052752544,0.0488212843091552,0.772050411761481
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43394,-0.00560110767635628,0.00896974789087304,-0.0231818135424674,0.0119795981897549,0.532345891338685
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43388,0.00865155252152077,0.0122080553227668,-0.0152762359111022,0.0325793409541437,0.478537367441936
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43417,0.00761032907480619,0.00967304415125648,-0.0113488374616565,0.0265694956112689,0.431437608836692
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43386,-0.00122174065214897,0.010950811286519,-0.0226853307737262,0.0202418494694282,0.91116893278937
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43380,-0.00400682104415557,0.0111025356162797,-0.0257677908520638,0.0177541487637527,0.718185237503442
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43400,-0.000927241481862132,0.00892402019621633,-0.0184183210664461,0.0165638381027219,0.917246991728912
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43416,-0.00534443359136747,0.0106379546610623,-0.0261948247270496,0.0155059575443146,0.615398904604822
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43558,-0.00483961822367353,0.00490242129576637,-0.0144483639633756,0.00476912751602855,0.323566436842679
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43470,0.000392620558202438,0.00674878386005694,-0.0128349958075092,0.013620236923914,0.953608861323368
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20127.Neuroticism score,44447,0.0535453783142091,0.0536346416837916,-0.0515785193860225,0.158669276014441,0.318132443497646
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35623,-0.0539566435369739,0.0845608896028522,-0.219695987158564,0.111782700084616,0.523444130796971
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X20161.Pack years of smoking,35781,-0.0023352194716198,0.00326990473216058,-0.00874423274665453,0.00407379380341493,0.475156516185625
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35781,-0.00239799599220279,0.00337984273869259,-0.00902248776004027,0.00422649577563469,0.478039806563601
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20191.Fluid intelligence score,33514,0.0354364852531406,0.102655176937629,-0.165767661544611,0.236640632050893,0.72996147098077
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33515,0.0496342318355266,0.104587541184258,-0.15535734888562,0.254625812556673,0.635116708014767
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20240.Maximum digits remembered correctly,32982,0.015558211979643,0.113210231508593,-0.206333841777199,0.237450265736485,0.890700124767854
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20255.Spirometry QC measure,43552,-0.102004899566594,0.0699657514381789,-0.239137772385425,0.0351279732522364,0.14488276488084
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X20261.avMSE,33586,-0.00326553404702329,0.00389441243376267,-0.0108985824171981,0.00436751432315155,0.401785601621216
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X20262.Myopia diagnosis,33586,0.0194269846654476,0.130471101872234,-0.23629637500413,0.275150344335025,0.881640361038224
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X20280.Glucose-lactate,40055,-0.00168501702792613,0.00251147917213226,-0.00660751620530535,0.00323748214945309,0.502281849934573
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X20281.Spectrometer-corrected alanine,40075,-0.00165356107079195,0.00257337698574807,-0.00669737996285816,0.00339025782127427,0.520520168352276
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35259,-0.0275130128809347,0.0150047796793531,-0.0569223810524668,0.00189635529059741,0.0667599049410547
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35259,-0.0129210696342038,0.0283918277298616,-0.0685690519847327,0.042726912716325,0.649054884347363
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35259,-0.00429699317318198,0.0451793925395991,-0.0928486025507962,0.0842546162044322,0.924230928688063
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35259,-0.0217576243697815,0.0138378041893018,-0.048879720580813,0.00536447184124994,0.115925703273996
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35259,0.0127660190065733,0.0288553617082405,-0.043790489941578,0.0693225279547246,0.658205350557618
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35263,-0.00240044346265979,0.0354643770090742,-0.0719106224004451,0.0671097354751256,0.946037786995217
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35263,-0.0073306208326901,0.0226958375570981,-0.0518144624446023,0.0371532207792221,0.746710864097914
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35263,-0.00685957964075695,0.026633032399044,-0.0590603231428833,0.0453411638613694,0.796755936710731
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35263,-0.0287116683543183,0.041404781999821,-0.109865041073968,0.0524417043653309,0.488060969105192
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35263,-0.0261273556891332,0.0473867129053933,-0.119005312983704,0.0667506016054377,0.581404065330958
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35263,-0.0102174949046503,0.0292340700318177,-0.067516272167013,0.0470812823577123,0.726721284917088
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35263,0.00832696140215363,0.0490901529713497,-0.0878897384216918,0.104543661225999,0.865310005594661
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35263,-0.0109462909154028,0.0345080475368532,-0.078582064087635,0.0566894822568295,0.751095324627138
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35262,0.018311883513233,0.0491035899060981,-0.0779311527027193,0.114554919729185,0.70921839304636
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35262,-0.00947199609587312,0.0186937659388,-0.046111777335921,0.0271677851441748,0.612388812786901
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35262,-0.0248842655896795,0.0354775601694757,-0.0944202835218518,0.0446517523424928,0.483074958530239
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35263,-0.0190552303464367,0.061888405018115,-0.140356504181942,0.102246043489069,0.758171568337123
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20600.Liking for adding salt to foods,35148,-0.0953829123063656,0.0904346517234496,-0.272634829684327,0.0818690050715956,0.29159790018015
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20601.Liking for aniseed,35148,0.043534953757244,0.0900386365959592,-0.132940773970836,0.220010681485324,0.62874853110925
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20602.Liking for apple juice,35148,-0.00473676370130098,0.0903749795555221,-0.181871723630124,0.172398196227522,0.958201906694561
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20603.Liking for apples,35148,0.0636426647610862,0.0915699752133061,-0.115834486656994,0.243119816179166,0.487071979616657
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20604.Liking for asparagus,35148,0.0802624412567653,0.0924916412166886,-0.101021175527944,0.261546058041475,0.385549541570319
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20605.Liking for aubergine,35148,-0.0280827105079838,0.0911908914018272,-0.206816857655565,0.150651436639597,0.758127199516248
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20606.Liking for avocados,35148,0.0942750545788298,0.092064609578171,-0.0861715801943853,0.274721689352045,0.305872351342699
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20607.Liking for bacon,35148,-0.149847276599283,0.0912504768506623,-0.328698211226581,0.0290036580280151,0.100611116625243
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20608.Liking for baked or steamed fish,35148,-0.0194625129294117,0.0931366175473125,-0.202010283322144,0.163085257463321,0.834480879769439
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20609.Liking for bananas,35148,0.0424698108222265,0.0937021917382427,-0.141186484984729,0.226126106629182,0.650390710968235
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35148,-0.176404472777709,0.090555745863556,-0.353893734670279,0.00108478911486096,0.0514594784461491
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20611.Liking for beef steak,35148,-0.155077102771407,0.0907314387954551,-0.332910722810499,0.0227565172676851,0.0874682880580275
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20612.Liking for beetroot,35148,-0.0152816394225669,0.0927573281116577,-0.197086002521416,0.166522723676282,0.869147467925058
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20613.Liking for bell pepper,35148,0.113335305677899,0.0905753384466678,-0.0641923576775704,0.290862969033367,0.210880785614743
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20614.Liking for bicycling,35148,0.0309535254207263,0.091204287051197,-0.14780687719962,0.209713928041072,0.734330396379681
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20615.Liking for biscuits,35148,-0.136662857281657,0.0905871195723736,-0.31421361164351,0.0408878970801948,0.131445342265496
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20616.Liking for bitter foods,35148,0.0327820280945583,0.0930194106681513,-0.149536016815018,0.215100073004135,0.724534770830056
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20617.Liking for bitter or ale,35148,-0.0704475724297827,0.0927238563760091,-0.252186330926761,0.111291186067195,0.447430147101169
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20618.Liking for black olives,35148,0.0750627442725403,0.091091309162545,-0.103476221686048,0.253601710231128,0.409950749313417
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20619.Liking for black pepper,35148,0.144661608327014,0.0913615743739884,-0.0344070774460035,0.323730294100031,0.113384283633725
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20620.Liking for blue cheese,35148,-0.0609559526090917,0.0913250865124353,-0.239953122173465,0.118041216955281,0.504503487151615
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20621.Liking for bolognese sauce,35148,-0.155452581878066,0.0910280552109605,-0.333867570091548,0.0229624063354169,0.087736131224108
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20622.Liking for broad beans,35148,-0.0231143433414546,0.0901607938398995,-0.199829499267658,0.153600812584748,0.797675557196069
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20623.Liking for broccoli,35148,0.054512488593985,0.0928600554332699,-0.127493220055224,0.236518197243194,0.557199701208675
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20624.Liking for brown rice,35148,0.0685174330460898,0.0909066792041318,-0.109659658194009,0.246694524286188,0.451052168755474
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20625.Liking for brussel sprouts,35148,-0.0348704575421832,0.0907858217834499,-0.212810668237745,0.143069753153379,0.700921142772264
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20626.Liking for burgers (meat),35148,-0.19374359304382,0.0892369741847466,-0.368648062445923,-0.0188391236417169,0.0299620291480964
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20627.Liking for burn of spicy foods,35148,-0.0918863980236008,0.0918700554542413,-0.271951706713914,0.0881789106667122,0.31726513528083
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20628.Liking for butter on bread,35148,-0.141237631527777,0.0919235548835651,-0.321407799099564,0.0389325360440109,0.124476774058613
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20629.Liking for butternut squash,35148,0.0294083929814584,0.0914688434194191,-0.149870540120603,0.20868732608352,0.747833207644706
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20630.Liking for cabbage,35148,-0.028444562947391,0.0926544563670834,-0.210047297426875,0.153158171532093,0.75885704213616
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20631.Liking for cake,35148,-0.0253772779778854,0.0910242519364024,-0.203784811773234,0.153030255817463,0.780410401457318
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20632.Liking for cake icing,35148,-0.0404587273989614,0.090044165881866,-0.216945292527419,0.136027837729496,0.653216548537483
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20633.Liking for capers,35148,0.0630039196756211,0.0898863720747475,-0.113173369590884,0.239181208942126,0.483375071978932
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20634.Liking for cauliflower,35148,0.0668534873753904,0.0930842474786329,-0.11559163768273,0.249298612433511,0.472659678502734
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20635.Liking for cereal or granola bar,35148,0.0462518839736571,0.0920217553796059,-0.13411075657037,0.226614524517685,0.615250775750517
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20636.Liking for cheesecake,35148,-0.0345564945265361,0.0910372881086541,-0.212989579219498,0.143876590166426,0.704266194729177
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20637.Liking for cherries,35148,0.0350687670150251,0.0956052676214504,-0.152317557523018,0.222455091553068,0.713775372375013
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20638.Liking for chicken,35148,-0.0136029320032512,0.0960575535610485,-0.201875736982906,0.174669872976404,0.887391041676842
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20639.Liking for chilli pepper,35148,0.0308942155552172,0.0911219650564145,-0.147704835955355,0.20949326706579,0.734589715757239
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20640.Liking for chips or french fries,35148,-0.202724116664424,0.0907283001519928,-0.38055158496233,-0.0248966483665183,0.0254932065542874
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20641.Liking for cigarette smoking,35148,0.0272128861868675,0.155663589685757,-0.277887749597217,0.332313521970952,0.861228149212339
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20642.Liking for cod,35148,-0.0279009213171231,0.0941971858306423,-0.212527405545182,0.156725562910936,0.767090006253636
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20643.Liking for coffee with sugar,35148,-0.186780919856165,0.0995116493774938,-0.381823752636053,0.00826191292372297,0.0605703973473944
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20644.Liking for coffee without sugar,35148,0.0800555025091711,0.0933774110919603,-0.102964223231071,0.263075228249413,0.391295632586499
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20645.Liking for coriander,35148,-0.0394841663011402,0.0904554026269145,-0.216776755449893,0.137808422847612,0.662486779068771
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20646.Liking for corn flakes,35148,-0.0295334636412106,0.09005862602951,-0.20604837065905,0.146981443376629,0.742971617994428
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20647.Liking for cream,35148,-0.0723263925253869,0.0916214203018691,-0.25190437631705,0.107251591266276,0.429906910251434
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20648.Liking for croissant,35148,-0.0461006777653577,0.0904526820734461,-0.223387934629312,0.131186579098597,0.610304231607909
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20649.Liking for cucumber,35148,0.0101641837974756,0.0907284589713944,-0.167663595786457,0.187991963381409,0.910804498318267
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20650.Liking for curry,35148,-0.0453850988511243,0.0920048987849521,-0.22571470046963,0.134944502767382,0.62182589611089
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20651.Liking for dairy products,35148,0.0523044574330947,0.0937070005820572,-0.131361263707737,0.235970178573927,0.57674917117032
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20652.Liking for dark chocolate,35148,-0.133646460557507,0.0919462672081812,-0.313861144285542,0.0465682231705279,0.146130035523241
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20653.Liking for diet fizzy drinks,35148,-0.151019072901247,0.0951112686216652,-0.337437159399711,0.0353990135972172,0.112381419682108
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20654.Liking for dried fruit,35148,-0.0096002296049338,0.0909232207720102,-0.187809742318074,0.168609283108206,0.915914304347594
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20655.Liking for eggs,35148,-0.104913469581169,0.0931086364697934,-0.287406397061964,0.0775794578996256,0.259878624554918
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20656.Liking for exercising alone,35148,-0.0145922883499202,0.0909726142083333,-0.192898612198253,0.163714035498413,0.872569006073364
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20657.Liking for exercising with others,35148,0.0192946758409213,0.0907900970253515,-0.158653914328768,0.19724326601061,0.83170896817501
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20658.Liking for extra virgin olive oil,35148,-0.0263436938853973,0.0919287613713935,-0.206524066173329,0.153836678402534,0.774454333283161
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20659.Liking for fatty foods,35148,-0.0663590294803861,0.0916426020063387,-0.24597852941281,0.113260470452038,0.469028675325926
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20660.Liking for fresh tomatoes,35148,0.0935539097537692,0.0978057635383813,-0.0981453867814581,0.285253206288997,0.338844654429208
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20661.Liking for fried chicken,35148,-0.172703216826549,0.0907338357752843,-0.350541534946107,0.00513510129300787,0.0570359962207632
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20662.Liking for fried or battered fish,35148,-0.172471008270576,0.0905121415478183,-0.349874805704299,0.00493278916314832,0.0567631239953543
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20663.Liking for fruit,35148,0.081056476664104,0.10379215489983,-0.122376146939563,0.284489100267771,0.434863036224863
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20664.Liking for garlic,35148,0.0397064530510882,0.0914670687999787,-0.13956900179687,0.218981907899047,0.664226827605001
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20665.Liking for gherkins,35148,0.0427038564980782,0.0910324612971893,-0.135719767644413,0.221127480640569,0.639011208525907
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20666.Liking for globe artichoke,35148,0.0871773354881719,0.0912818020664814,-0.0917349965621317,0.266089667538475,0.339598719917941
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20667.Liking for goat's cheese,35148,-0.0101847798610244,0.0908425293572063,-0.188236137401149,0.1678665776791,0.910736273845707
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20668.Liking for going to a cafe,35148,0.0122627945722869,0.0910629066463274,-0.166220502454515,0.190746091599089,0.892882970584166
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20669.Liking for going to the gym,35148,0.0268945423713644,0.0896947568961304,-0.148907181145051,0.20269626588778,0.76430571851019
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20670.Liking for going to the pub,35148,-0.146676371010235,0.090897969761837,-0.324836391743435,0.0314836497229658,0.106659155078235
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20671.Liking for grapefruit,35148,0.0615664634132878,0.0892548554269043,-0.113373053223445,0.23650598005002,0.490357715225349
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20672.Liking for green olives,35148,0.0366006722845105,0.0906940411792551,-0.141159648426829,0.21436099299585,0.686549318611492
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20673.Liking for haddock,35148,-0.0978268911278583,0.0946658453098214,-0.283371947935108,0.0877181656793916,0.301462702235955
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20674.Liking for ham,35148,-0.152632947116677,0.0917448895664878,-0.332452930666993,0.0271870364336395,0.0962316960301541
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20675.Liking for hard cheese,35148,-0.0546265070451207,0.0929799426942641,-0.236867194725878,0.127614180635637,0.556884553498362
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20676.Liking for herring,35148,-0.0453705853425073,0.0908977055072799,-0.223530088136776,0.132788917451761,0.617699968411454
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20677.Liking for honey,35148,-0.11321250937945,0.0903049758024059,-0.290210261952166,0.0637852431932654,0.210011795628386
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20678.Liking for horseradish or wasabi,35148,-0.114513418465686,0.0912631438000352,-0.293389180313755,0.0643623433823828,0.209614919408712
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20679.Liking for ice cream,35148,-0.102325297131137,0.0923081395901639,-0.283249250727858,0.0785986564655842,0.267682718667465
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20680.Liking for jam,35148,-0.0853532394797193,0.0901756264872448,-0.262097467394719,0.0913909884352805,0.34392073380351
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20681.Liking for kiwi fruit,35148,0.00720342827306298,0.0918893328216517,-0.172899664057374,0.1873065206035,0.937518531681372
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20682.Liking for lager,35148,0.0485439985159251,0.0901681426532526,-0.12818556108445,0.2252735581163,0.590340445268023
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20683.Liking for lamb,35148,-0.037152688487034,0.0925325461880684,-0.218516479015648,0.14421110204158,0.688059539529456
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20684.Liking for lemons,35148,0.0254842869892205,0.0907443642932834,-0.152374667025615,0.203343241004056,0.778845940178766
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20685.Liking for lentils or beans,35148,0.0395136979338036,0.0912849971075651,-0.139404896397024,0.218432292264631,0.665131593680965
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20686.Liking for liver,35148,-0.210949567275251,0.0908873267789287,-0.389088727761951,-0.0328104067885509,0.0203204490455181
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20687.Liking for mackerel,35148,0.0572629945873838,0.0917772807524552,-0.122620475687428,0.237146464862196,0.532694664363045
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20688.Liking for marzipan,35148,0.143283620436028,0.0899440823594306,-0.0330067809884564,0.319574021860512,0.111206626236138
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20689.Liking for mayonnaise,35148,-0.0575182769259979,0.0919125972081744,-0.23766696745402,0.122630413602024,0.531474625623407
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20690.Liking for melon,35148,0.0677200710467564,0.0938377969149922,-0.116202010906628,0.251642153000141,0.470524801423179
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20691.Liking for milk chocolate,35148,-0.0959669579214605,0.0906653805141254,-0.273671103729146,0.0817371878862253,0.289882352876065
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20692.Liking for mushrooms,35148,0.0209472903646403,0.0929373315272601,-0.161209879428789,0.20310446015807,0.821682422179496
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20694.Liking for orange juice,35148,0.0290372171168276,0.0901977166493311,-0.147750307515861,0.205824741749517,0.747518167963385
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20695.Liking for oranges,35148,0.0300202318632248,0.0924839291606686,-0.151248269291686,0.211288733018135,0.745495669761076
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20696.Liking for pasta,35148,-0.0698648130151348,0.0927107938032661,-0.251577968869536,0.111848342839267,0.451132511672133
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20697.Liking for pears,35148,0.0413724100553755,0.0936699554526462,-0.142220702631811,0.224965522742562,0.658734807906557
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20698.Liking for pizza,35148,-0.0227667561241888,0.0912045719144585,-0.201527717076527,0.15599420482815,0.802887557593458
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20699.Liking for plain yogurt,35148,0.0777868801686033,0.091211418621486,-0.100987500329509,0.256561260666716,0.393793741906865
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20700.Liking for plums,35148,-0.00595629776722764,0.0933044931933249,-0.188833104426145,0.176920508891689,0.949102002068673
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20701.Liking for pollock,35148,-0.0625981753323399,0.0908561129991108,-0.240676156810597,0.115479806145917,0.490861836218607
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20702.Liking for pork chop,35148,-0.0589162146497938,0.0898607119290365,-0.235043210030705,0.117210780731118,0.512081600718588
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20703.Liking for porridge,35148,-0.0719879498166121,0.0936234022936923,-0.255489818312249,0.111513918679025,0.441977414954995
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20704.Liking for potato crisps,35148,-0.171639543032927,0.0912047781943122,-0.350400908293779,0.00712182222792523,0.0598965116206718
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20705.Liking for potatoes,35148,-0.0986731450224541,0.0913473861315319,-0.277714021840257,0.0803677317953485,0.280098409424696
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20706.Liking for prawns,35148,0.0594116236592231,0.0925794803903651,-0.122044157905892,0.240867405224339,0.521069083838867
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20707.Liking for raw carrots,35148,-0.0315577469067689,0.0908808801245716,-0.209684271950929,0.146568778137391,0.728421081635734
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20708.Liking for red meat,35148,-0.195331819135202,0.0917807029938341,-0.375221997003117,-0.0154416412672872,0.0333577929251928
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20709.Liking for red wine,35148,0.0351609206829859,0.0912596841124326,-0.143708060177382,0.214029901543354,0.70004059913514
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35148,-0.121480499449669,0.0934238465470126,-0.304591238681814,0.0616302397824758,0.193543177181137
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20711.Liking for roast chicken,35148,-0.153448829291621,0.0952539846121242,-0.340146639131384,0.0332489805481427,0.107245028651475
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20712.Liking for salad dressing,35148,0.0350870112157718,0.0918158035378644,-0.144871963718442,0.215045986149986,0.702366981893159
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20713.Liking for salad leaves,35148,0.168615477744021,0.0926486470535974,-0.0129758704810302,0.350206825969071,0.0688175864939066
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20714.Liking for salami,35148,-0.0342141398556005,0.0902975644524237,-0.211197366182351,0.14276908647115,0.704772425855878
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20715.Liking for salmon,35148,0.0514103513493719,0.0969931877129037,-0.138696296567919,0.241516999266663,0.596103405299373
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20716.Liking for salty foods,35148,-0.120762947291717,0.0907707791398398,-0.298673674405803,0.0571477798223695,0.183432092973276
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20717.Liking for salty pretzels,35148,-0.109650201501623,0.091076404067655,-0.288159953474227,0.0688595504709806,0.228662079943651
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20718.Liking for sardines,35148,-0.0100899763351654,0.0913971342619372,-0.189228359488562,0.169048406818232,0.912098198749618
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20719.Liking for sausages (meat),35148,-0.222209197035634,0.0897461091724086,-0.398111571013555,-0.0463068230577131,0.0133148980173739
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20720.Liking for savoury biscuits,35148,-0.0638424653841794,0.0919858013508966,-0.244134636031937,0.116449705263578,0.487679880767544
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35148,-0.090822284881196,0.0910342445520397,-0.269249404203194,0.0876048344408017,0.31847921014524
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20722.Liking for skimmed milk,35148,0.0464701930297114,0.0893611520130004,-0.128677664915769,0.221618050975192,0.603064265884587
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20723.Liking for smoked fish,35148,-0.0695307693870963,0.0921235101727034,-0.250092849325595,0.111031310551402,0.450425313046006
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20724.Liking for soft cheese,35148,0.0343512976910752,0.0922882311426622,-0.146533635348543,0.215236230730693,0.709744160496071
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20725.Liking for soy sauce,35148,0.0476728528578034,0.0917597669069543,-0.132176290279827,0.227521995995434,0.603403693381131
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20726.Liking for soya milk,35148,-0.169912564955609,0.0923412883224144,-0.350901490067541,0.0110763601563233,0.0658107528260776
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20727.Liking for spicy foods,35148,0.0426906338217033,0.0915106114109584,-0.136670164543775,0.222051432187182,0.640867440468567
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20728.Liking for spinach,35148,0.0517667982258689,0.0925150237179732,-0.129562648261359,0.233096244713096,0.575807374059657
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20729.Liking for spirits,35148,-0.0813962028215735,0.0910965447559355,-0.259945430543207,0.09715302490006,0.371617178657237
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20730.Liking for strawberries,35148,-0.213071736725196,0.0999513342474409,-0.40897635185018,-0.0171671216002119,0.033067895587008
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35148,-0.260524842540592,0.0931889907854144,-0.443175264480004,-0.0778744206011802,0.00519598741019039
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20732.Liking for sweet foods,35148,-0.237386241543496,0.0912163063402359,-0.416170201970359,-0.0586022811166337,0.00927889638293256
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20733.Liking for taking the stairs,35148,-0.0408778059545984,0.0931786546426246,-0.223507969054143,0.141752357144946,0.660892301204878
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20734.Liking for tea with sugar,35148,-0.014091843443261,0.110935401361139,-0.231525230111093,0.203341543224571,0.898922952213189
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20735.Liking for tea without sugar,35148,-0.0673713861163005,0.095759825773861,-0.255060644633068,0.120317872400467,0.481743468684857
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20736.Liking for tomato ketchup,35148,-0.0477988984258218,0.0904010933316491,-0.224985041355854,0.12938724450421,0.597003841884216
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20737.Liking for tinned tuna,35148,-0.0973177934609309,0.0915137791552701,-0.27668480060526,0.0820492136833985,0.287633676891846
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20738.Liking for turnip (white),35148,-0.164445855398405,0.0906593631964504,-0.342138207263448,0.0132464964666377,0.069745491704121
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20739.Liking for vegetables,35148,-0.025965353350745,0.0984557477947898,-0.218938619028533,0.167007912327043,0.79200009975301
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20740.Liking for vinegar,35148,0.0537260024997723,0.090727342696026,-0.124099589184439,0.231551594183983,0.553759335260126
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20741.Liking for watching television,35148,-0.180783230639275,0.0922471643245929,-0.361587672715478,2.12114369266547e-05,0.0500693245418165
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20742.Liking for whisky,35148,0.0216090441574569,0.0931702565797831,-0.161004658738918,0.204222747053832,0.816599811061308
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20743.Liking for white bread,35148,-0.0155699143956312,0.0905106287187487,-0.192970746684379,0.161830917893116,0.863425263199714
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20744.Liking for white rice,35148,-0.220067379313105,0.0908001581302478,-0.398035689248391,-0.042099069377819,0.0153952536508623
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20745.Liking for white wine,35148,-0.111690738782311,0.0910355392798043,-0.290120395770728,0.066738918206105,0.219911919993947
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35148,0.0510915791280847,0.0925441770768291,-0.1302950079425,0.23247816619867,0.580915852268741
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20747.Liking for whole milk,35148,-0.0406272886173571,0.0903284049336203,-0.217670962287253,0.136416385052539,0.652890438923416
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20748.Liking for wholemeal bread,35148,0.101074207532939,0.0959054038388217,-0.0869003839911513,0.28904879905703,0.291973908452752
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20749.Liking for working up a sweat,35148,-0.028879469050885,0.0911666401810431,-0.207566083805729,0.14980714570396,0.751424154309112
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21001.Body mass index (BMI),48522,-0.00683723718573471,0.00874927162300033,-0.0239858095668153,0.0103113351953459,0.434539456947108
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21002.Weight,48534,0.00211031781703435,0.00469949118967863,-0.00710068491473578,0.0113213205488045,0.653398885489295
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21021.Pulse wave Arterial Stiffness index,35874,0.000349893462826864,0.00321386855695789,-0.0059492889088106,0.00664907583446433,0.913308972137193
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34965,-0.0201092814067607,0.0960964203083416,-0.20845826521111,0.168239702397589,0.834251494569352
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34979,0.05912516896339,0.0978444637519374,-0.132649979990407,0.250900317917187,0.545683136674039
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34981,0.00776513193463531,0.0963031426861385,-0.180989027730196,0.196519291599467,0.935737266564573
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21040.Satisfaction with bowel habits,34938,-0.0363713953534809,0.089811217421121,-0.212401381498878,0.139658590791916,0.685510193407153
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34919,0.102129371690185,0.096935876110387,-0.0878649454861733,0.292123688866544,0.292121335930923
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21042.Greatest number of times bowels opened per day,34940,-0.091804789967518,0.0963950342115096,-0.280739057022077,0.0971294770870407,0.340943906152577
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21043.Least number of times bowels opened per week,34883,-0.00554638590984869,0.0964149597229434,-0.194519706966818,0.18342693514712,0.954128059597674
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21044.Average number of times bowels opened per day,34910,-0.00874347548081826,0.10767300470229,-0.219782564697307,0.202295613735671,0.935282589059865
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34982,-0.0294085403120812,0.0963956471269097,-0.218344008680824,0.159526928056662,0.760314960086058
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34978,0.133396257239904,0.0981398609855479,-0.0589578702917695,0.325750384771578,0.174121509371574
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32251,0.108023432799312,0.172445945191249,-0.229970619775537,0.446017485374161,0.531086875305641
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34981,-0.0474289825450922,0.112275428053488,-0.267488821529928,0.172630856439744,0.672723803703646
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34980,0.00719653127338495,0.146514703582348,-0.279972287748018,0.294365350294788,0.96082683442396
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34977,0.0777673977114247,0.112515741991097,-0.142763456591125,0.298298252013974,0.489487063490429
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34977,-0.212855927766857,0.275247947012331,-0.752341903911026,0.326630048377312,0.439362087667725
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34983,0.00127373317021957,0.114985477402485,-0.224097802538652,0.226645268879091,0.991162124367792
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34980,0.14392673135768,0.105672243938951,-0.063190866762664,0.351044329478024,0.173247526352761
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34848,0.0230306571890604,0.101477980243326,-0.175866184087859,0.221927498465979,0.82046907059788
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34977,-0.128986653768597,0.0969508334602524,-0.319010287350691,0.0610369798134978,0.183427894000763
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34979,0.026497901073149,0.156610859235413,-0.280459383028261,0.333455185174559,0.865648542583965
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34984,0.0366881544567372,0.0989157066806566,-0.15718663063735,0.230562939550824,0.710723185802784
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34983,-0.0831572862525852,0.0969124024658159,-0.273105595085584,0.106791022580414,0.390891272649955
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X21100.Water hardness (USGS classification),48490,-0.10402063950098,0.052625235166022,-0.207166100426383,-0.000875178575576605,0.0480976404982191
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2139.Age first had sexual intercourse,45328,0.00142830467293241,0.00216834401717763,-0.00282164960073574,0.00567825894660057,0.510092954749309
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2149.Lifetime number of sexual partners,44331,-0.0127418332286675,0.0591292827974445,-0.128635227511659,0.103151561054324,0.829387366468674
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22032.IPAQ activity group,44329,-0.0594976756081683,0.0594611226773009,-0.176041476055678,0.0570461248393415,0.317029100874669
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22033.Summed days activity,44749,-0.0015999332660454,0.00210963332481903,-0.0057348145826907,0.0025349480505999,0.448226636055814
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22034.Summed minutes activity,44329,-0.00318090447824805,0.00208818220213995,-0.00727374159444236,0.000911932637946263,0.127707370627644
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22037.MET minutes per week for walking,43497,-0.00301105328164751,0.00223354164618053,-0.00738879490816136,0.00136668834486633,0.177645297091969
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22038.MET minutes per week for moderate activity,44329,-0.00166817632885384,0.00203382526155859,-0.00565447384150866,0.00231812118380099,0.412105813126811
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22039.MET minutes per week for vigorous activity,44329,-0.0470389674005129,0.0597372856644883,-0.16412404730291,0.0700461125018841,0.431042164306186
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22040.Summed MET minutes per week for all activity,43497,-0.00200900303558383,0.00216814871171967,-0.00625857451055438,0.00224056843938673,0.354150742279833
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X2217.Age started wearing glasses or contact lenses,46936,0.000189038175573465,0.00179035652250614,-0.00332006060853856,0.00369813695968549,0.91591132124138
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X22501.Year ended full time education,33356,0.00797797330041252,0.00895989116053997,-0.00958341337424581,0.0255393599750709,0.373297443933257
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X22506.Tobacco smoking,33333,0.0779201388532992,0.23664414480517,-0.385902384964835,0.541742662671433,0.741967259827014
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47503,0.438490550192557,0.179637099758174,0.0864018346665349,0.790579265718578,0.0146568783003747
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23098.Weight,48128,0.00264768241865105,0.00475769634946847,-0.00667740242630716,0.0119727672636093,0.577872166395643
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23099.Body fat percentage,48120,-0.00367173944118924,0.00453451623009223,-0.01255939125217,0.00521591236979154,0.418104840318709
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23100.Whole body fat mass,48107,-0.00143314814437804,0.00447006656529091,-0.0101944786123482,0.00732818232359215,0.748509483167964
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23101.Whole body fat-free mass,48127,0.00450217060123715,0.00387003388329664,-0.00308309581002426,0.0120874370124986,0.244705679768213
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23102.Whole body water mass,48128,0.00430674845811746,0.00388150193215772,-0.00330099532891167,0.0119144922451466,0.267203970323962
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23104.Body mass index (BMI),48128,-0.00314390066205142,0.00875705520057413,-0.0203077288551767,0.0140199275310739,0.719589025348909
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23105.Basal metabolic rate,48128,0.00449542291660574,0.00413299229141794,-0.00360524197457341,0.0125960878077849,0.276744917655357
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23106.Impedance of whole body,48125,-0.00366335805708155,0.0031672413073627,-0.00987115101951245,0.00254443490534935,0.247434058528662
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23107.Impedance of leg (right),48128,3.35411562017919e-05,0.00256764059592697,-0.00499903441181507,0.00506611672421865,0.989577647183923
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23108.Impedance of leg (left),48128,-0.000319983869810593,0.00254422645830015,-0.00530666772807889,0.0046666999884577,0.899916411464468
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23109.Impedance of arm (right),48126,-0.00273337728528403,0.00312521429845355,-0.00885879731025299,0.00339204273968492,0.38179138654667
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23110.Impedance of arm (left),48128,-0.00377753473130983,0.00313602623985279,-0.00992414616142131,0.00236907669880164,0.228387897769532
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23111.Leg fat percentage (right),48128,-0.00152092011585176,0.00535368511073027,-0.0120141429328831,0.00897230270117958,0.776345702971261
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23112.Leg fat mass (right),48128,-0.000694347024801601,0.00586816160087714,-0.0121959437625208,0.0108072497129176,0.905811836198517
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23113.Leg fat-free mass (right),48127,0.000719726520491174,0.00394767067753051,-0.00701770800746863,0.00845716104845098,0.855336099862309
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23114.Leg predicted mass (right),48127,0.000584664587477832,0.00396932879335708,-0.00719521984750205,0.00836454902245771,0.882900289351844
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23115.Leg fat percentage (left),48125,-0.00326007306995798,0.00560817615801814,-0.0142520983396735,0.00773195219975757,0.561040362915678
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23116.Leg fat mass (left),48125,-0.00200005051603894,0.00612303553299414,-0.0140012001607074,0.0100010991286296,0.743941055728881
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23117.Leg fat-free mass (left),48124,0.00185031270091066,0.00414428076659804,-0.0062724776016215,0.00997310300344282,0.655260155285321
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23118.Leg predicted mass (left),48124,0.00184397070577851,0.00416957667013826,-0.00632839956769247,0.0100163409792495,0.658317625314743
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23119.Arm fat percentage (right),48124,-0.00213385851728991,0.00510404180954626,-0.0121377804640006,0.00787006342942075,0.675898996308123
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23120.Arm fat mass (right),48122,-0.000851467494338281,0.00510601183953989,-0.0108592506998365,0.00915631571115991,0.867562375883935
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23121.Arm fat-free mass (right),48123,0.00244938133516371,0.00395455861240969,-0.00530155354515927,0.0102003162154867,0.535672371909544
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23122.Arm predicted mass (right),48123,0.0026453800311241,0.00396275859362208,-0.00512162681237518,0.0104123868746234,0.504422490481703
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23123.Arm fat percentage (left),48122,-0.00702671983873756,0.00523426326465696,-0.0172858758374652,0.00323243615999009,0.179467277053476
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23124.Arm fat mass (left),48122,-0.00369937140471649,0.00511326167941508,-0.01372136429637,0.00632262148693706,0.469390513094938
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23125.Arm fat-free mass (left),48122,0.00247237108936653,0.00403946419379795,-0.00544497873047744,0.0103897209092105,0.540509239711013
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23126.Arm predicted mass (left),48120,0.00390005991233656,0.0040430830971537,-0.0040243829580847,0.0118245027827578,0.33474488894742
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23127.Trunk fat percentage,48120,-0.00331832565340991,0.00324055692890872,-0.00966981723407099,0.00303316592725118,0.305849039420922
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23128.Trunk fat mass,48120,-0.00125961347938425,0.00362593924750941,-0.0083664544045027,0.0058472274457342,0.728302530153976
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23129.Trunk fat-free mass,48119,0.00567742311714138,0.00349997999232418,-0.00118253766781401,0.0125373839020968,0.104792138357495
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23130.Trunk predicted mass,48116,0.00542981182149318,0.00351672051188876,-0.00146296038180879,0.0123225840247952,0.12260537583566
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23400.Total Cholesterol,40080,0.000871064102472092,0.00252138147512227,-0.00407084358876755,0.00581297179371173,0.72974700664218
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40080,0.00108159063767024,0.00243926706360683,-0.00369937280699916,0.00586255408233963,0.657479430457104
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40080,0.000117182375045743,0.0024348583238079,-0.00465513993961775,0.00488950468970923,0.961615927973278
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23403.VLDL Cholesterol,40080,-0.000626762677221951,0.00246840983408406,-0.00546484595202672,0.00421132059758281,0.799567150141934
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23404.Clinical LDL Cholesterol,40080,0.00187212178927107,0.00243677998380973,-0.00290396697899601,0.00664821055753814,0.442339356565707
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23405.LDL Cholesterol,40080,0.00188954199308487,0.00244733332175703,-0.00290723131755891,0.00668631530372865,0.440082625973995
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23406.HDL Cholesterol,40080,0.000261876681920926,0.00283796702486393,-0.00530053868681238,0.00582429205065423,0.926480331929778
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23407.Total Triglycerides,40080,-0.0021303864880944,0.002661100883046,-0.00734614421886456,0.00308537124267575,0.423400498755749
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23408.Triglycerides in VLDL,40080,-0.00214246321730715,0.00265033719852734,-0.00733712412642074,0.00305219769180644,0.418893080638629
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23409.Triglycerides in LDL,40080,-0.000429183028599801,0.00265239902302245,-0.00562788511372381,0.0047695190565242,0.871458972985554
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23410.Triglycerides in HDL,40080,-0.00310929084889495,0.00260157786833788,-0.0082083834708372,0.0019898017730473,0.232052204379876
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40080,-0.00105617146618252,0.0026182240503588,-0.00618789060488577,0.00407554767252073,0.686667560596287
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23412.Phospholipids in VLDL,40080,-0.00119206633710766,0.00254672159216414,-0.00618364065774937,0.00379950798353404,0.639737624170797
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23413.Phospholipids in LDL,40080,0.00190734149810759,0.00243427074013242,-0.00286382915255196,0.00667851214876714,0.433328807819268
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23414.Phospholipids in HDL,40080,-0.00175384780655247,0.00280581715845142,-0.00725324943711725,0.0037455538240123,0.531934551912354
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23415.Total Esterified Cholesterol,40080,0.00097075492733279,0.00253509504683163,-0.00399803136445721,0.00593954121912279,0.70178178140716
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40080,-0.00033302498116317,0.00243961396540467,-0.00511466835335633,0.00444861839102999,0.891422821782322
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40080,0.00169837198404832,0.00245001790979491,-0.00310366311914969,0.00650040708724634,0.488193825430746
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40080,0.000400614798533959,0.00282230851061405,-0.00513110988226958,0.0059323394793375,0.887125455560606
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23419.Total Free Cholesterol,40080,0.000631618443570862,0.0024898249338321,-0.00424843842674005,0.00551167531388178,0.799747684430236
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23420.Free Cholesterol in VLDL,40080,-0.000997212856042803,0.00251818331487065,-0.00593285215318928,0.00393842644110368,0.692109196647392
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23421.Free Cholesterol in LDL,40080,0.00230660615035006,0.00245212143232647,-0.00249955185700982,0.00711276415770994,0.346901332899538
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23422.Free Cholesterol in HDL,40080,-0.000351212500260783,0.00286255111412004,-0.00596181268393607,0.0052593876834145,0.902353159110107
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40080,-0.000478699021692473,0.00251663479030559,-0.00541130321069143,0.00445390516730649,0.849145033892643
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23424.Total Lipids in VLDL,40080,-0.00153653705448968,0.00257992052585998,-0.00659318128517524,0.00352010717619588,0.551471333318908
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23425.Total Lipids in LDL,40080,0.00177941161824796,0.00244634932901863,-0.00301543306662854,0.00657425630312447,0.467012339223468
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23426.Total Lipids in HDL,40080,-0.00110537870158957,0.00282634851849403,-0.00664502179783788,0.00443426439465873,0.695732597121469
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40080,-0.000235416825223211,0.00266933337403921,-0.00546731023834006,0.00499647658789364,0.929724811679733
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23428.Concentration of VLDL Particles,40080,-0.000739032503026205,0.00251232845047648,-0.00566319626596011,0.0041851312599077,0.768639438447767
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23429.Concentration of LDL Particles,40080,0.00133737312844065,0.00242148717006022,-0.00340874172487739,0.00608348798175869,0.580758196348251
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23430.Concentration of HDL Particles,40080,-0.000330327297940779,0.00267337501621907,-0.00557014232973015,0.0049094877338486,0.901664441351548
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40080,-0.00138285395952042,0.00270352869205586,-0.00668177019594991,0.00391606227690907,0.609011613253563
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23432.Average Diameter for LDL Particles,40080,0.00367027242132537,0.00256580957440145,-0.00135871434450148,0.00869925918715221,0.152615477478817
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23433.Average Diameter for HDL Particles,40080,-0.000570212058986284,0.00290136816020237,-0.00625689365298292,0.00511646953501035,0.844197357065816
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23434.Phosphoglycerides,40070,-0.00172249418587818,0.00267065735096406,-0.00695698259376773,0.00351199422201138,0.518960155001125
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40070,-0.00190503853708768,0.00277472438186002,-0.00734349832553332,0.00353342125135797,0.492369280373683
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23436.Total Cholines,40070,-0.00117998051647033,0.00267594958256466,-0.00642484169829706,0.00406488066535641,0.659252400610774
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23437.Phosphatidylcholines,40070,-0.00143680336426221,0.00269606471922807,-0.00672109021394923,0.00384748348542481,0.594095597913058
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23438.Sphingomyelins,40070,0.00112420791516584,0.00262329128993572,-0.00401744301310818,0.00626585884343986,0.668260215839849
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23439.Apolipoprotein B,40080,0.00113307657817258,0.00242185578485515,-0.00361376076014351,0.00587991391648867,0.639897876130679
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23440.Apolipoprotein A1,40080,-0.00111254991821636,0.0027581397987647,-0.00651850392379517,0.00429340408736245,0.686684223838818
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40080,0.00169590987656652,0.00247817540776371,-0.00316131392265036,0.0065531336757834,0.49377625485506
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23442.Total Fatty Acids,40070,-0.00224571000588811,0.00258965538844926,-0.00732143456724867,0.00283001455547244,0.385859849228515
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23443.Degree of Unsaturation,40070,-0.00232688307033004,0.00260784802622271,-0.00743826520172655,0.00278449906106648,0.372272385923638
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23444.Omega-3 Fatty Acids,40070,-0.00392627534159541,0.00259005789702931,-0.00900278881977285,0.00115023813658204,0.129573060194207
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23445.Omega-6 Fatty Acids,40070,-0.0015039997976586,0.00255422731018832,-0.0065102853256277,0.0035022857303105,0.555989089356608
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40070,-0.00221281789438564,0.00258926969339036,-0.00728778649343075,0.00286215070465948,0.392785459871183
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40070,-0.00222957134920287,0.00264651030692532,-0.0074167315507765,0.00295758885237076,0.399550678623737
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23448.Saturated Fatty Acids,40070,-0.00166646169708142,0.00259038466625891,-0.00674361564294889,0.00341069224878605,0.5200261797279
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23449.Linoleic Acid,40070,-0.0008110908663492,0.00249863609723846,-0.00570841761693658,0.00408623588423818,0.745479894816721
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23450.Docosahexaenoic Acid,40070,-0.000861811663674591,0.00259013870491197,-0.00593848352530204,0.00421486019795286,0.739346026768797
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40070,-0.0035093074297605,0.00254952632841364,-0.00850637903345123,0.00148776417393022,0.168709247394381
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40070,0.00167959403227803,0.00276631878297566,-0.00374239078235426,0.00710157884691033,0.543758388587815
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40070,0.00033139743169407,0.00272467467137015,-0.00500896492419142,0.00567175978757956,0.903195680638199
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40070,-0.00150219295104368,0.00276853012598442,-0.00692851199797314,0.00392412609588578,0.587419216308402
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40070,0.000916080556899101,0.00251125789216305,-0.00400598491174048,0.00583814602553868,0.715275622554801
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40070,0.00215400380944473,0.00265234947450529,-0.00304460116058564,0.0073526087794751,0.416745364376018
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40070,0.000671830368316487,0.00254989012157639,-0.00432595426997324,0.00566961500660621,0.792190065222529
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40070,0.0011430277300701,0.00276743353781416,-0.00428114200404565,0.00656719746418586,0.679594191200164
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40070,0.00386149034212014,0.00252736166728362,-0.00109213852575577,0.00881511920999604,0.126572889184688
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23460.Alanine,40075,-0.00328547242082432,0.00251142658341868,-0.00820786852432492,0.00163692368267629,0.190829853542384
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23461.Glutamine,40041,0.00329745226785231,0.00250992243414268,-0.00162199570306735,0.00821690023877196,0.188952544894072
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23462.Glycine,40066,0.00706958310516434,0.0026608024890049,0.00185441022671475,0.0122847559836139,0.00789695140503872
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23463.Histidine,40064,0.000309729462058578,0.00247005702671117,-0.00453158231029532,0.00515104123441248,0.900214235260524
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40073,-0.00256353196861593,0.00261153949946595,-0.00768214938756919,0.00255508545033732,0.326310322725666
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23465.Isoleucine,40077,-0.00192104651013343,0.00254374293201644,-0.00690678265688565,0.00306468963661879,0.450142537512445
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23466.Leucine,40077,-0.00107111169875339,0.00256772780157681,-0.00610385818984395,0.00396163479233716,0.676581467025541
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23467.Valine,40073,-0.00320768650336898,0.00264379181972761,-0.0083895184700351,0.00197414546329714,0.225045259705054
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23468.Phenylalanine,40074,-0.00271097464030142,0.00250057847112855,-0.00761210844371338,0.00219015916311053,0.278327196813649
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23469.Tyrosine,40066,-0.00225134231848301,0.00254463923739056,-0.00723883522376851,0.00273615058680248,0.376316824030767
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23470.Glucose,40059,-0.000796481071164343,0.00248835462437281,-0.00567365613493506,0.00408069399260637,0.748911244936653
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23471.Lactate,40060,0.000200982087438474,0.0024992337444711,-0.00469751605172488,0.00509948022660183,0.935906703410508
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23472.Pyruvate,40043,0.000514288729694227,0.00249414139016188,-0.00437422839502306,0.00540280585441151,0.836639567028466
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23473.Citrate,40078,0.00330105755103376,0.00249662686006909,-0.00159233109470167,0.00819444619676918,0.1861270103913
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23474.3-Hydroxybutyrate,39898,-0.000478134894569145,0.00261526599236206,-0.00560405623959878,0.00464778645046049,0.854939127682822
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23475.Acetate,40069,0.000560082031338578,0.00246500879765152,-0.00427133521205841,0.00539149927473557,0.820262394473821
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23476.Acetoacetate,40079,-0.00356365539595764,0.00253238163898888,-0.00852712340837585,0.00139981261646057,0.159386348912197
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23477.Acetone,40079,-0.00369129061716986,0.00250161248474035,-0.00859445108726095,0.00121186985292123,0.140089761088005
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23478.Creatinine,39830,0.000773641009947233,0.00289644553933788,-0.004903392247155,0.00645067426704947,0.789397238102247
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23479.Albumin,40077,0.003566710977174,0.00250738438268049,-0.00134776241287976,0.00848118436722775,0.154914822636197
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23480.Glycoprotein Acetyls,40080,-0.00438945393249061,0.00266910896815933,-0.00962090751008289,0.000841999645101683,0.100093778492659
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40080,-0.00393901298559801,0.00267406545174292,-0.00918018127101413,0.00130215529981811,0.140768394917885
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40080,-0.0042824755958507,0.0026395577857286,-0.00945600885587877,0.000891057664177363,0.104742062380834
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40080,-0.00386000600301124,0.0026816752064685,-0.0091160894076895,0.00139607740166702,0.150065691321406
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40080,-0.0037211551172328,0.00265081268904381,-0.00891674798775866,0.00147443775329306,0.160413202545262
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40080,-0.00282639551250345,0.00261756380224132,-0.00795682056489643,0.00230402953988953,0.280263661333883
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40080,-0.00398723120883822,0.00267635622465672,-0.00923288940916539,0.00125842699148895,0.136306224046249
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40080,-0.00387446783941214,0.00261780548147896,-0.0090053665831109,0.00125643090428662,0.138890387670387
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40080,-0.00183822277666216,0.00266412758934366,-0.00705991285177572,0.00338346729845141,0.490214858787175
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40080,-0.0018543128960977,0.00265082511609027,-0.00704993012363463,0.00334130433143924,0.484240247896357
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40080,-0.0020480918212677,0.00264460747952561,-0.00723152248113789,0.0031353388386025,0.438687008163762
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40080,-0.00149374725400271,0.0025829430813235,-0.00655631569339676,0.00356882118539135,0.563065385468042
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40080,-0.000871351579675165,0.0025408047051913,-0.00585132880185012,0.00410862564249979,0.731647847747398
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40080,-0.00215381382364375,0.00262553655031221,-0.00729986546225569,0.00299223781496819,0.412044358509195
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40080,-0.00194822834250473,0.00266667717172091,-0.00717491559907772,0.00327845891406825,0.465049774043209
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40080,-0.00142992978906265,0.00263186375967655,-0.00658838275802869,0.00372852317990339,0.586924395072785
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23496.Total Lipids in Large VLDL,40080,-0.00122914363174481,0.00261665839478123,-0.00635779408551601,0.0038995068220264,0.638551692150114
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23497.Phospholipids in Large VLDL,40080,-0.00131092739528384,0.00262967441582191,-0.00646508925029478,0.00384323445972711,0.618132443063047
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23498.Cholesterol in Large VLDL,40080,-0.00106925153214031,0.00257855849314996,-0.00612322617871423,0.00398472311443361,0.678391474291835
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40080,-0.000712455275080412,0.00253320843470426,-0.00567754380710077,0.00425263325693995,0.778526908196538
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40080,-0.00136147581602465,0.00262502403811075,-0.00650652293072173,0.00378357129867242,0.604013491009193
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23501.Triglycerides in Large VLDL,40080,-0.00140550669867402,0.0026108967646832,-0.0065228643574531,0.00371185096010506,0.590364838442507
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40080,8.0174380349902e-05,0.00247099215892186,-0.00476297025113694,0.00492331901183674,0.974116790368446
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40080,-2.44717540601123e-05,0.00249763397495485,-0.00491983434497161,0.00487089083685139,0.992182652021276
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40080,0.000281428222878882,0.00246094424004349,-0.00454202248760636,0.00510487893336413,0.908956256903634
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40080,0.000915076132479882,0.00241843012502275,-0.0038250469125647,0.00565519917752446,0.705158606502598
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40080,0.00114200623442499,0.00242759250692206,-0.00361607507914225,0.00590008754799224,0.638059056937444
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40080,0.000475661882844917,0.00244374261372957,-0.00431407364006503,0.00526539740575487,0.845674631649897
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40080,-0.000685233602424302,0.00259017040647048,-0.00576196759910644,0.00439150039425784,0.791359954439764
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40080,-0.000310521735806257,0.00254863950902676,-0.00530585517349871,0.0046848117018862,0.903029382365314
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23510.Total Lipids in Small VLDL,40080,-0.00038464304930172,0.00254110154631944,-0.00536520208008781,0.00459591598148437,0.879687742003056
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23511.Phospholipids in Small VLDL,40080,0.000390773702130714,0.00248348058586441,-0.00447684824616354,0.00525839565042496,0.874972559423839
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23512.Cholesterol in Small VLDL,40080,0.000580804554449435,0.00245817603296715,-0.00423722047016618,0.00539882957906505,0.813224041911422
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40080,0.000379614467795648,0.00246919537334181,-0.00446000846395429,0.00521923739954559,0.877817475504078
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40080,0.000880383060092543,0.0024421807314636,-0.00390629117357611,0.0056670572937612,0.718487321120988
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23515.Triglycerides in Small VLDL,40080,-0.00172309208736354,0.0026359168101973,-0.00688948903535025,0.00344330486062318,0.513320556249366
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40080,-0.000822684052396052,0.00248393253238973,-0.00569119181587992,0.00404582371108781,0.740498093154373
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40080,-0.00117105483443595,0.00250641822477209,-0.00608363455498926,0.00374152488611735,0.64035009308528
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40080,-0.00126391410356674,0.00250654225460713,-0.00617673692259671,0.00364890871546323,0.614098668833883
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40080,-0.000695085479585091,0.0024770518091506,-0.00555010702552027,0.00415993606635009,0.77901488652814
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40080,-0.000560137341485616,0.00248159094799146,-0.00542405559954887,0.00430378091657764,0.821425748203229
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40080,-0.000987990790760739,0.00248691049012996,-0.00586233535141545,0.00388635376989398,0.691171453909428
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40080,-0.00180332670320159,0.00263524756015932,-0.00696841192111386,0.00336175851471067,0.493793894356504
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23523.Concentration of IDL Particles,40080,0.00117806297129186,0.00241566720590786,-0.00355664475228755,0.00591277069487126,0.625789159964895
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23524.Total Lipids in IDL,40080,0.000816133033362934,0.00248991617935619,-0.0040641026781752,0.00569636874490107,0.743087864368478
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23525.Phospholipids in IDL,40080,0.000727218738013188,0.00249195495018158,-0.00415701296434271,0.00561145044036908,0.77042476769736
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23526.Cholesterol in IDL,40080,0.00106615864081799,0.00249036360273915,-0.00381495402055075,0.00594727130218673,0.66857685197187
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40080,0.00111501649095296,0.00249393262096345,-0.0037730914461354,0.00600312442804132,0.654817770814171
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23528.Free Cholesterol in IDL,40080,0.000831135158586769,0.00247790765087196,-0.00402556383712228,0.00568783415429581,0.737316154549701
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23529.Triglycerides in IDL,40080,-0.00119206137061463,0.00264039737368633,-0.00636724022303983,0.00398311748181057,0.651659517053031
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23530.Concentration of Large LDL Particles,40080,0.00173563160839812,0.00242124418328864,-0.0030100069908476,0.00648127020764385,0.47349153783464
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23531.Total Lipids in Large LDL,40080,0.00183605356932473,0.00246162970386657,-0.00298874065025374,0.0066608477889032,0.455762588741791
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23532.Phospholipids in Large LDL,40080,0.00170573341764471,0.00244510522974184,-0.00308667283264931,0.00649813966793872,0.485435114552705
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23533.Cholesterol in Large LDL,40080,0.00198051945570557,0.00246603985999966,-0.00285291866989377,0.0068139575813049,0.421924431054157
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40080,0.00194825798372876,0.00246521997389365,-0.00288357316510279,0.00678008913256031,0.429371071766984
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40080,0.00209773964830429,0.00247118959795566,-0.00274579196368879,0.00694127126029738,0.395967585477532
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23536.Triglycerides in Large LDL,40080,-0.000305913722154292,0.00264619117151227,-0.00549244841831835,0.00488062097400977,0.907967495205121
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40080,0.000518345235821069,0.00243661625929458,-0.0042574226323963,0.00529411310403844,0.831540313523809
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23538.Total Lipids in Medium LDL,40080,0.00162368557885931,0.00245209346022461,-0.00318241760318093,0.00642978876089955,0.507880776542578
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23539.Phospholipids in Medium LDL,40080,0.00202427125769953,0.00244546508633789,-0.00276884031152274,0.0068173828269218,0.407821548364967
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23540.Cholesterol in Medium LDL,40080,0.00158709860524727,0.00244656290442679,-0.00320816468742924,0.00638236189792379,0.516542487330247
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40080,0.00118735859836091,0.00245934483873675,-0.00363295728556313,0.00600767448228495,0.629251238750687
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40080,0.00253725938502623,0.00243894687587887,-0.00224307649169635,0.00731759526174882,0.298219277958133
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23543.Triglycerides in Medium LDL,40080,-0.000221434593614923,0.00265819675664993,-0.00543150023664878,0.00498863104941893,0.933612496801336
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23544.Concentration of Small LDL Particles,40080,0.000933618153173287,0.00242063122661096,-0.0038108190509842,0.00567805535733077,0.699732308357785
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23545.Total Lipids in Small LDL,40080,0.00174872119864931,0.00242705653907772,-0.00300830961794302,0.00650575201524164,0.471225833137144
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23546.Phospholipids in Small LDL,40080,0.00218222762783106,0.0024091924035322,-0.00253978948309206,0.00690424473875418,0.365065910486666
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23547.Cholesterol in Small LDL,40080,0.00179004076067719,0.00242534947011072,-0.00296364420073983,0.0065437257220942,0.460497073098391
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40080,0.00127229175388185,0.00244053206770152,-0.00351115109881312,0.00605573460657683,0.602156308856917
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40080,0.00274434364241193,0.00241937964104948,-0.00199764045404506,0.00748632773886891,0.256686545573394
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23550.Triglycerides in Small LDL,40080,-0.00154292645015064,0.00266480324945949,-0.00676594081909124,0.00368008791878997,0.562599793539478
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40080,0.000360386923728616,0.00277296816400397,-0.00507463067771916,0.0057954045251764,0.896597056436221
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40080,0.000195655760151473,0.00278532395858881,-0.00526357919868259,0.00565489071898554,0.943999754301343
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40080,-3.73003450133751e-05,0.00279994553387168,-0.00552519359140186,0.00545059290137511,0.989371291249621
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40080,0.000972283866744152,0.00276005702270221,-0.00443742789775219,0.00638199563124049,0.724642989743382
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40080,0.00103013676506553,0.00279225756763787,-0.00444268806750468,0.00650296159763575,0.71218996450563
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40080,0.00110353370519182,0.00263037423485479,-0.00405199979512358,0.00625906720550721,0.674833556959799
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40080,-0.0016632292998419,0.00259652147572779,-0.00675241139226836,0.00342595279258456,0.521821701498052
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23558.Concentration of Large HDL Particles,40080,0.000134549565853955,0.00291990642724392,-0.00558846703154413,0.00585756616325204,0.963247256201869
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23559.Total Lipids in Large HDL,40080,9.30531461217794e-05,0.00292308249327272,-0.00563618854069274,0.0058222948329363,0.974605087362848
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23560.Phospholipids in Large HDL,40080,-0.000274721449752819,0.00291931500636725,-0.00599657886223263,0.00544713596272699,0.925027667949617
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23561.Cholesterol in Large HDL,40080,0.000588105938594642,0.00289591507816495,-0.00508788761460866,0.00626409949179794,0.839075353367744
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40080,0.000798485329967905,0.00289090628235303,-0.00486769098344403,0.00646466164337984,0.782395180212822
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40080,-8.25091183623442e-05,0.00289621821264638,-0.00575909681514925,0.00559407857842456,0.977273005522226
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23564.Triglycerides in Large HDL,40080,-0.0028359960229241,0.00267097974491178,-0.00807111632295118,0.00239912427710298,0.288358590439341
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40080,-0.00146078640080337,0.00273197308609937,-0.00681545364955814,0.0038938808479514,0.592868142808158
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23566.Total Lipids in Medium HDL,40080,-0.00178644567221151,0.00270667138412141,-0.00709152158508948,0.00351863024066647,0.509257702942856
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23567.Phospholipids in Medium HDL,40080,-0.00228272854542975,0.00268901936885259,-0.00755320650838082,0.00298774941752132,0.395951465977441
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23568.Cholesterol in Medium HDL,40080,-0.000627992923666233,0.00272792109816849,-0.00597471827607647,0.004718732428744,0.817933427802148
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40080,-0.000518363775012908,0.00271246388655787,-0.00583479299266634,0.00479806544264052,0.848447366833795
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40080,-0.00104307588634452,0.00277721239224421,-0.00648641217514318,0.00440026040245414,0.707233680234985
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23571.Triglycerides in Medium HDL,40080,-0.00358319705262605,0.00258710356190399,-0.00865392003395786,0.00148752592870577,0.166073920662866
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23572.Concentration of Small HDL Particles,40080,0.00060968101331027,0.00249518766713061,-0.00428088681426572,0.00550024884088626,0.806969982821954
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23573.Total Lipids in Small HDL,40080,-0.000616224406027385,0.00251390689527665,-0.00554348192076962,0.00431103310871485,0.806363349315676
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23574.Phospholipids in Small HDL,40080,-0.00130201132564102,0.00252898552782675,-0.00625882296018145,0.00365480030889941,0.606678484751066
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23575.Cholesterol in Small HDL,40080,0.00110911032939678,0.00249469299736084,-0.00378048794543046,0.00599870860422402,0.656626429315726
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40080,0.00135921010212774,0.00247580437769021,-0.00349336647814508,0.00621178668240056,0.583018511881005
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40080,0.000132133449546501,0.00256832360588543,-0.00490178081798895,0.00516604771708195,0.958969996910506
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23578.Triglycerides in Small HDL,40080,-0.00229842783671041,0.00263984286782058,-0.00747251985763874,0.00287566418421793,0.383954421633361
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39665,-0.000732746690571957,0.00250710549650682,-0.00564667346372532,0.00418118008258141,0.770087519678806
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39665,0.00341280598131821,0.00257905836411319,-0.00164214841234365,0.00846776037498007,0.185772510050083
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39665,0.0037918581177636,0.00254746738133373,-0.00120117794965051,0.00878489418517772,0.136654067135138
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39665,0.00129042983649146,0.00259431219124031,-0.00379442205833955,0.00637528173132248,0.618912299329047
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39665,-0.00136102078475429,0.00255873981312051,-0.0063761508184705,0.00365410924896191,0.594799212095923
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39987,-0.00187259508566965,0.00251783165622268,-0.00680754513186611,0.00306235496052681,0.457054067945408
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39987,0.00235334697685496,0.00264223544982571,-0.00282543450480343,0.00753212845851336,0.373128701064543
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39987,0.00320595976633157,0.00264845691898953,-0.00198501579488791,0.00839693532755104,0.226113212672796
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39987,-0.000664431501837527,0.00260293560094135,-0.00576618527968256,0.00443732227600751,0.798525328242029
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39987,-0.0015611686872563,0.00259572023977317,-0.00664878035721172,0.00352644298269913,0.547559927123735
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40079,-8.34094030573619e-05,0.00259134897332947,-0.00516245339078312,0.00499563458466839,0.974323004552063
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40079,0.000771383824922468,0.00251350754329374,-0.00415509095993327,0.0056978586097782,0.758928884621594
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40079,0.00161951065026925,0.00258186186437328,-0.00344093860390237,0.00667995990444088,0.530498935331351
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40079,-0.000294608626348623,0.00247759120116815,-0.00515068738063819,0.00456147012794095,0.905349410874658
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40079,-0.000995225124591166,0.00247071595254407,-0.00583782839157753,0.0038473781423952,0.68709709632829
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40080,0.00188374607024019,0.00251143846167958,-0.00303867331465178,0.00680616545513216,0.453230813369316
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40080,0.00194476806196697,0.00260865349249082,-0.00316819278331505,0.00705772890724898,0.455981696045933
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40080,0.00190954044523158,0.00263560181600261,-0.00325623911413354,0.00707532000459671,0.468763470579804
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40080,0.00166675520963934,0.00254366960227659,-0.00331883721082278,0.00665234763010145,0.512316679065636
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40080,-0.00203586795057578,0.0025838463379949,-0.00710020677304579,0.00302847087189423,0.430759809975385
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40080,0.00303769438834203,0.0026037985906673,-0.00206575084936588,0.00814113962604994,0.243381524800912
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40080,0.00284178613473967,0.00253816565056419,-0.00213301854036614,0.00781659080984547,0.262899573113237
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40080,0.00244291962039945,0.00249168469711551,-0.00244078238594695,0.00732662162674585,0.326896251143429
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40080,0.00295133870898217,0.00261365481000106,-0.00217142471861991,0.00807410213658424,0.258838404714973
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40080,-0.00293977163161967,0.00256000801037149,-0.00795738733194779,0.00207784406870845,0.250851525571952
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40080,-0.000698330726354623,0.0025469352152799,-0.00569032374830322,0.00429366229559397,0.78394787016529
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40080,0.00137826427544495,0.00263715483627956,-0.00379055920366298,0.00654708775455289,0.601240272305846
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40080,0.00149054712693881,0.00265870877767101,-0.00372052207729637,0.00670161633117398,0.575062558314809
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40080,-0.000672874802445553,0.00249948516747854,-0.0055718657307035,0.00422611612581239,0.787776758361798
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40080,-0.00109548126575396,0.00262568026778954,-0.00624181459062145,0.00405085205911353,0.676527133266538
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40080,-0.000742944024523859,0.00241382656069855,-0.00547404408349302,0.0039881560344453,0.758250432168739
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40080,0.00196105460298192,0.00255235218647598,-0.00304155568251101,0.00696366488847484,0.442306461913469
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40080,0.00233278399518504,0.00255736603057925,-0.00267965342475029,0.00734522141512038,0.361692966263341
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40080,-0.000530701333916754,0.00244063920817191,-0.00531435418193371,0.0042529515141002,0.827866744593664
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40080,-0.00215887918892326,0.00262734483230085,-0.00730847506023292,0.0029907166823864,0.411267834328463
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40080,-0.00227504813843793,0.00244090805020306,-0.00705922791683593,0.00250913163996006,0.351331400783157
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40080,0.00406435824267991,0.00263794241329271,-0.0011060088873738,0.00923472537273362,0.12341146464516
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40080,0.00325690991251836,0.00244854113982892,-0.00154223072154633,0.00805605054658304,0.183499018655134
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40080,0.00176986801662514,0.00263432623339597,-0.00339341140083096,0.00693314743408124,0.50169443350207
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40080,-0.00296282448853269,0.00263091220820438,-0.00811941241661327,0.0021937634395479,0.26012320620252
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40080,0.00363788295962934,0.00248629225030162,-0.00123524985096184,0.00851101577022052,0.143448118225777
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40080,0.000660226153893597,0.00243266356705853,-0.00410779443754112,0.00542824674532831,0.786088149375136
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40080,-0.00204880843641513,0.00251279775837258,-0.00697389204282539,0.00287627516999513,0.41489011100382
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40080,0.00368153621901623,0.00268921144074582,-0.00158931820484557,0.00895239064287803,0.171026851173949
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40080,-0.00275654012864298,0.00258498772023886,-0.00782311606031114,0.00231003580302519,0.286282378654913
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40080,0.0015403157001448,0.00246710305922868,-0.00329520629594341,0.00637583769623302,0.532416185864805
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40080,0.00149863378919324,0.00247981563287326,-0.00336180485123835,0.00635907242962483,0.545635034315078
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40080,-0.00200075984031943,0.00246966084062703,-0.00684129508794842,0.00283977540730955,0.417880030290985
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40080,0.00464173006224477,0.00263276631089234,-0.000518491907104222,0.00980195203159376,0.0779180972973788
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40080,-0.00373098842096784,0.00263260580657192,-0.0088908958018488,0.00142891895991313,0.156446477620266
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40072,-0.00218620330986689,0.00273523519533673,-0.00754726429272689,0.0031748576729931,0.424148804905707
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40072,0.00409457609938814,0.00258909815933651,-0.000980056292911429,0.0091692084916877,0.113800124331234
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40072,0.00215938869704426,0.00252213616941485,-0.00278399819500884,0.00710277558909736,0.391920118942194
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40072,0.00125125081469037,0.0028817289158735,-0.00439693786042169,0.00689943948980243,0.664150786811176
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40072,-0.00146648882829461,0.00273753340851976,-0.00683205430899333,0.00389907665240412,0.592178829962457
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40080,-0.00280957857442834,0.00267238683032139,-0.00804745676185826,0.00242829961300158,0.293127275733946
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40080,0.00361402131510903,0.00276418588856328,-0.001803783026475,0.00903182565669305,0.191089198850522
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40080,0.00361650307740685,0.00278064919654935,-0.00183356934782989,0.00906657550264358,0.193424080034339
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40080,0.000503592001115812,0.00261424411196335,-0.00462032645833235,0.00562751046056398,0.847249298478894
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40080,-0.00248520785940363,0.0027383145722299,-0.00785230442097424,0.00288188870216698,0.364126369316044
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40080,-0.00320305104697916,0.00271591635132996,-0.00852624709558587,0.00212014500162755,0.238279466245947
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40080,0.00318164731921273,0.00268924985675316,-0.00208928240002346,0.00845257703844893,0.236795971432478
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40080,0.00318432187784502,0.0026654695684655,-0.00203999847634737,0.00840864223203741,0.232247097048476
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40080,0.00111392288082661,0.00284042332490597,-0.00445330683598908,0.0066811525976423,0.694941829815142
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40080,-0.00290786666674447,0.00264943334903978,-0.00810075603086244,0.00228502269737349,0.272428429634277
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40080,-0.00502154346859108,0.0025754178317294,-0.0100693624187807,2.62754815985519e-05,0.0512258873301262
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40080,0.00478477350416441,0.00257684049357164,-0.00026583386323601,0.00983538087156483,0.0633613005235687
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40080,0.00405032355200118,0.00260004394184902,-0.0010457625740229,0.00914640967802526,0.119312006536256
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40080,0.00294926633122441,0.0025876415823778,-0.00212251117023607,0.00802104383268489,0.254415250856988
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40080,-0.00244322602865464,0.00267501891026686,-0.00768626309277769,0.00279981103546841,0.361079210851816
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48366,0.000643163702843108,0.00213345543580972,-0.00353840895134394,0.00482473635703016,0.76306264735696
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48366,0.00145179691041423,0.00208222829599391,-0.00262937054973383,0.00553296437056229,0.485665856464148
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47063,-0.000345929485920572,0.00198218467566473,-0.00423101145022344,0.0035391524783823,0.861459339906709
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47063,0.000568538752217547,0.00218427591764134,-0.00371264204635947,0.00484971955079457,0.794645354028222
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47063,-0.000628346481544422,0.00211759755044963,-0.0047788376804257,0.00352214471733686,0.766679070940576
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47063,0.000114962920665757,0.00194546659382246,-0.00369815160322626,0.00392807744455778,0.952878914641432
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24009.Traffic intensity on the nearest road,48366,-0.0344323835585294,0.116295982817781,-0.26237250988138,0.193507742764322,0.767175681324655
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24010.Inverse distance to the nearest road,48366,0.000475644855411105,0.00187517525585505,-0.0031996986460648,0.00415098835688701,0.799765944327173
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24011.Traffic intensity on the nearest major road,48366,0.000151296069843767,0.00184316725252528,-0.00346131174510577,0.00376390388479331,0.934580113529626
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24012.Inverse distance to the nearest major road,48366,0.000645003021262191,0.00189137234557805,-0.00306208677607079,0.00435209281859517,0.733089387090349
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24013.Total traffic load on major roads,48366,0.0647212671333126,0.0815622173727425,-0.0951406789172627,0.224583213183888,0.427484625471353
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24015.Sum of road length of major roads within 100m,48366,0.00138683378156545,0.0791517206446026,-0.153750538681856,0.156524206244987,0.986020996029813
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48366,-0.000333076709818117,0.00212374247786218,-0.004495611966428,0.00382945854679176,0.875376703524486
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48366,-0.000117032117263763,0.0021195080995505,-0.00427126799238274,0.00403720375785521,0.955966447132497
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48366,-0.000255225069904858,0.00209573298858204,-0.00436286172752566,0.00385241158771595,0.90307199563661
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48318,0.000621914891087163,0.00208827949575195,-0.00347111292058666,0.00471494270276099,0.765849817998466
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24020.Average daytime sound level of noise pollution,48366,-0.000189804298446367,0.00187859976177128,-0.00387185983151808,0.00349225123462535,0.919523744891961
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24021.Average evening sound level of noise pollution,48366,-0.000169535922149055,0.00187916219638139,-0.00385269382705658,0.00351362198275847,0.928114218202741
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24022.Average night-time sound level of noise pollution,48366,-0.000188661532966383,0.00187851382876414,-0.0038705486373441,0.00349322557141133,0.920002994078901
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48366,-0.000171889079211771,0.00187884360746232,-0.00385442254983792,0.00351064439141438,0.927106881284296
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48366,-0.000179527193702744,0.00187886792075143,-0.00386210831837555,0.00350305393097006,0.923878399726656
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2405.Number of children fathered,38270,0.02812908432336,0.0934811944125122,-0.155094056725164,0.211352225371884,0.763492806308146
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",46301,0.00141017733721516,0.00219396629631451,-0.00288999660356129,0.00571035127799161,0.520393318830882
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",46301,-0.00326393340268904,0.00197105315311078,-0.00712719758278617,0.000599330777408087,0.0977535806224036
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24502.Water percentage, buffer 1000m",46301,-3.88687042846547e-05,0.00199659938719511,-0.00395220350318708,0.00387446609461777,0.984468428077818
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24503.Greenspace percentage, buffer 300m",46301,0.00230288346042968,0.00205138207480737,-0.00171782540619277,0.00632359232705212,0.261622768020796
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",46301,-0.00328832026916548,0.00198031834680342,-0.00716974422890019,0.000593103690569226,0.0968320666269177
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24505.Water percentage, buffer 300m",46301,0.00198011613254287,0.00202092125186151,-0.0019808895211057,0.00594112178619144,0.327194435246851
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48490,0.000881255714018067,0.00209745563930627,-0.00322975733902222,0.00499226876705835,0.67437716898463
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48490,0.000492325435207212,0.00196979086212526,-0.00336846465455829,0.00435311552497272,0.802638016718625
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24508.Distance (Euclidean) to coast,48490,0.000720520958468819,0.00185359168892612,-0.00291251875182638,0.00435356066876401,0.697490449586746
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,34545,-0.025204854201245,0.108561055042953,-0.237984522085433,0.187574813682944,0.816413181770238
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2704.Years since last cervical smear test,37025,-0.0144165216375565,0.0897470398363929,-0.190320719716886,0.161487676441774,0.872384978521383
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2714.Age when periods started (menarche),39058,0.00939318568278243,0.0724783863796368,-0.132664451621306,0.151450822986871,0.896885689743069
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2734.Number of live births,39362,-0.0595769225145691,0.0707467831680729,-0.198240617523992,0.0790867724948538,0.399743443428939
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2744.Birth weight of first child,37811,0.111796145247232,0.0754843464941573,-0.036153173881316,0.25974546437578,0.13862965659133
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2754.Age at first live birth,36771,0.000338149902386846,0.00341393710401007,-0.00635316682147288,0.00702946662624658,0.921101322925599
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2764.Age at last live birth,36747,0.00521413449961076,0.00313561659007716,-0.000931674016940482,0.011359943016162,0.0963791965127209
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2794.Age started oral contraceptive pill,35846,0.00267152744085817,0.00487363491192719,-0.00688079698651912,0.0122238518682355,0.583601038299555
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2804.Age when last used oral contraceptive pill,35200,0.00653826361686681,0.00372064774884974,-0.000754205970878684,0.0138307332046123,0.078919027726832
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2867.Age started smoking in former smokers,35107,-0.00137588210593559,0.00353284004419353,-0.00830024859255491,0.00554848438068373,0.696953639634933
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34993,0.00506458306572293,0.118254251162517,-0.226713749212809,0.236842915344255,0.965840186119998
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34991,0.0471615409100069,0.129021893588693,-0.205721370523832,0.300044452343846,0.71472818548386
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35003,0.0551344940948541,0.134049156532115,-0.207601852708091,0.317870840897799,0.680867332009274
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34978,0.20129066984478,0.130052218975101,-0.0536116793464178,0.456193019035977,0.121732879227125
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28739.Difficulty with standing for long periods,35004,-0.0232038936914733,0.101653616358207,-0.222444981753559,0.176037194370613,0.819448797409988
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28740.Difficulty with taking care of household responsibilities,35026,-0.0568897770072656,0.112109790322468,-0.276624966039303,0.162845412024772,0.611860411689584
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28741.Difficulty learning a new task,34970,0.0255375478434474,0.128907097185666,-0.227120362640458,0.278195458327353,0.8429674159278
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28742.Difficulty with joining in community activities,34754,0.04006426385867,0.138240991719954,-0.23088807991244,0.311016607629779,0.7719688566119
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28743.Difficulty with being emotionally affected by health problems,34996,0.0427154536722559,0.115951031629915,-0.184548568322378,0.26997947566689,0.712594272283646
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35027,-0.0355677547716683,0.177252220728377,-0.382982107399287,0.31184659785595,0.840970008278803
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34720,-0.0526882550503077,0.104642481642332,-0.257787519069278,0.152411008968662,0.614627707891574
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2897.Age stopped smoking,35104,-0.00485081674026765,0.00332585745779249,-0.0113694973575409,0.00166786387700563,0.144751464190149
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34417,0.00790534022914076,0.00849348567743717,-0.0087418916986361,0.0245525721569176,0.352024184090834
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34417,-0.00806904017143429,0.00948454522697189,-0.0266587488162992,0.0105206684734306,0.394943532306688
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34417,0.00407891884617151,0.0322899181052988,-0.0592093206402141,0.0673671583325571,0.89948210526406
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34417,0.0588261562068861,0.037977893865033,-0.0156105157685787,0.133262828182351,0.121452443347237
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34417,0.0404103257754677,0.0450922432389246,-0.0479704709728245,0.12879112252376,0.370203156403512
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34417,0.0414217437464901,0.0372238630759339,-0.0315370278823403,0.11438051537532,0.265856754125257
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34417,-0.021572264995577,0.0155507305819192,-0.0520516969361387,0.00890716694498467,0.165434260098428
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34417,-0.0411176525898555,0.0269051052108025,-0.0938516588030284,0.0116163536233174,0.126511720452827
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29002.Recent lack of interest or pleasure in doing things,34387,-0.0931825961475216,0.135107567221841,-0.35799342790233,0.171628235607287,0.490418783769331
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29003.Recent feelings of depression,34377,-0.016826765326815,0.13002323573483,-0.271672307367082,0.238018776713452,0.897035469481867
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34390,-0.12105709919927,0.102107643351431,-0.321188080168075,0.0790738817695341,0.23584120458188
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29005.Recent feelings of tiredness or low energy,34393,0.0410733199396485,0.102390956757281,-0.159612955304622,0.241759595183919,0.688332023353805
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29006.Recent poor appetite or overeating,34402,0.123217661205486,0.152176863856724,-0.175048991953694,0.421484314364665,0.418149418393791
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29007.Recent feelings of inadequacy,34373,-0.00646110515011685,0.145350781173128,-0.291348636249448,0.278426425949214,0.964545979279063
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29008.Recent trouble concentrating on things,34400,0.0590458825740651,0.143045632104401,-0.221323556350562,0.339415321498692,0.679787338441264
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34395,0.0579188887524552,0.239193436386193,-0.410900246564483,0.526738024069394,0.808679323948548
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29010.Recent thoughts of suicide or self-harm,34376,-0.316143670144374,0.285707489598474,-0.876130349757383,0.243843009468635,0.268548931425305
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#0.Substances taken for depression_None of options listed,35206,0.0282957589727138,0.0159214014485206,-0.00291018786638646,0.0595017058118141,0.0755833612011028
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35206,0.00471350016015275,0.0395638332376241,-0.0728316129855906,0.0822586133058961,0.905171123405305
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35206,-0.0119479745010661,0.0161021185150956,-0.0435081267906534,0.0196121777885213,0.45810870020391
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35206,-0.0355949166049101,0.048911577014221,-0.131461607552783,0.0602717743429631,0.466801030070606
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35206,-0.00861157653547711,0.0400140413050184,-0.0870390974933131,0.0698159444223589,0.829607880561128
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35206,0.00124542210102167,0.0426009257252418,-0.0822523923204523,0.0847432365224956,0.976678436396522
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35206,-0.0228338112723347,0.0457954817578962,-0.112592955517811,0.0669253329731418,0.618076613960683
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35206,0.0280514294325471,0.0444271063996834,-0.0590256991108324,0.115128557975927,0.527800748395333
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35206,-0.0398361902901392,0.0284045503962767,-0.0955091090668416,0.0158367284865632,0.160830143178405
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35206,0.00880147824305945,0.0145959344510963,-0.0198065532810893,0.0374095097672082,0.546525520752936
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35206,0.0285505228633394,0.025465504483894,-0.0213618659250928,0.0784629116517716,0.262270929052279
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35206,0.0111785306511404,0.0409777474860725,-0.0691378544215617,0.0914949157238425,0.78502005940948
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35206,0.0385240191838688,0.0564073787639809,-0.0720344431935337,0.149082481561271,0.494658033794237
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35206,0.116476037573396,0.0394946360049915,0.0390665510036121,0.193885524143179,0.00319865458934435
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35206,0.0678648505361656,0.0551147160958875,-0.040159993011774,0.175889694084105,0.218244597068823
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35206,0.0132865878317674,0.051768604369107,-0.0881798767316824,0.114753052395217,0.797455137583468
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35206,0.0160186023518639,0.0313052281889772,-0.0453396448985314,0.0773768496022593,0.608886105253333
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35206,0.00868853716582466,0.030214204656948,-0.0505313039617935,0.0679083782934428,0.773689919507741
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35206,-0.0368177610786703,0.0437462188768668,-0.122560350077329,0.0489248279199886,0.400033291000322
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29058.Recent feelings or nervousness or anxiety,34313,0.00869319065786165,0.121610626703853,-0.229663637681691,0.247050018997414,0.943015504752403
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29059.Recent inability to stop or control worrying,34324,-0.116997952907454,0.123819484572099,-0.359684142668768,0.125688236853859,0.344750648049649
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29060.Recent worrying too much about different things,34322,0.0634372912899787,0.115425536675769,-0.162796760594528,0.289671343174486,0.582621170390233
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29061.Recent trouble relaxing,34322,-0.0273999150283191,0.125729047865537,-0.273828848844772,0.219029018788134,0.827493667600754
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29062.Recent restlessness,34334,0.25249018672618,0.174760035018033,-0.0900394819091649,0.595019855361526,0.148580054505765
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29063.Recent easy annoyance or irritability,34306,0.157503248386073,0.126624011843257,-0.0906798148267119,0.405686311598857,0.213606099881202
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29064.Recent feelings of foreboding,34309,-0.0715014471667027,0.143253354265961,-0.352278021527985,0.20927512719458,0.617712226411621
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35206,-0.00814818236325517,0.0182984156020687,-0.0440130769433097,0.0277167122167994,0.656123032294181
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35206,-0.0415094954804372,0.0312894208457191,-0.102836760338047,0.0198177693771721,0.184681377285552
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35206,-0.0784359955428584,0.0395365122273726,-0.155927559508509,-0.00094443157720811,0.047313780339922
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35206,-0.0506362851526207,0.0377956464899311,-0.124715752272886,0.0234431819676443,0.180380992713392
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#2.Symptoms of panic attack_Sweating,35206,-0.0251510127289499,0.027466064329846,-0.078984498815448,0.0286824733575482,0.359854543361553
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35206,-0.0139055191641135,0.0302610144557736,-0.0732171074974298,0.0454060691692028,0.64587793494635
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35206,-0.00254353301343701,0.0300373301819243,-0.0614167001700085,0.0563296341431345,0.932519359967968
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35206,0.0235935760607671,0.030651327525748,-0.036483025889699,0.0836701780112331,0.441483930111418
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35206,-0.00711579183136076,0.0370937457256087,-0.0798195334535537,0.0655879497908322,0.84787976732876
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29076.Felt loved as a child,34307,-0.153238959598766,0.104434482579234,-0.357930545454065,0.0514526262565335,0.142350164705047
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29077.Physically abused by family as a child,34327,0.0869586756317038,0.149997549591784,-0.207036521568194,0.380953872831601,0.562119486837296
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29078.Felt hated by family member as a child,34312,0.13613026733292,0.149404687241807,-0.156702919661022,0.428963454326862,0.362258623465093
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29079.Sexually molested as a child,34273,0.293624307057111,0.181063824516428,-0.0612607889950879,0.648509403109309,0.104937866061117
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29080.Someone to take to doctor when needed as a child,34291,-0.126929311480755,0.142738125643008,-0.406696037741051,0.15283741477954,0.373912860355139
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34317,0.247146950373997,0.210522884722914,-0.165477903682915,0.659771804430908,0.240462766986405
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34284,0.126199593205865,0.165844309300513,-0.19885525302314,0.451254439434871,0.446720870901067
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34322,-0.0252088870290128,0.195136370077601,-0.407676172381112,0.357258398323086,0.89721554147368
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34309,-0.110229312008993,0.278506831898343,-0.656102702529746,0.43564407851176,0.692278867465567
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34309,-0.0895356074486211,0.246828855630565,-0.573320164484528,0.394248949587285,0.716811357585605
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29086.Experienced a violent or sexual assault,34323,-0.747217902581601,0.255333604324739,-1.24767176705809,-0.246764038105113,0.00344373816867604
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29087.Experienced a life-threatening injury or illness,34320,-0.0342360107508845,0.117492457653018,-0.2645212277508,0.196049206249031,0.770765612327481
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29088.Experienced a marital separation or divorce,34321,-0.0586086339728706,0.118168378609584,-0.290218656047656,0.173001388101914,0.619932881316684
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29089.Experienced the death of a spouse or partner,34330,0.0932329605571563,0.127363336210992,-0.156399178416388,0.3428650995307,0.46418760558177
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34321,0.0641720794490185,0.150300333973777,-0.230416575139585,0.358760734037622,0.669427126405807
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29091.Frequency of drinking alcohol,34317,0.146688702481142,0.0940492168671118,-0.0376477625783971,0.331025167540681,0.118892247726092
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33684,-0.0747329829077054,0.123205241409635,-0.316215256070589,0.166749290255179,0.54416495644743
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33705,-0.258224942588907,0.127380019516171,-0.507889780840602,-0.00856010433721138,0.0427005579129695
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29104.Ever used cannabis,34319,-0.0771502341652228,0.17456883075691,-0.419305142448767,0.265004674118322,0.658545955358965
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29108.Ever thought that life not worth living,34294,-0.0292502121124111,0.129731060914957,-0.283523091505728,0.225022667280906,0.821624196971623
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29109.Ever contemplated self-harm,34312,0.173956936930714,0.188266569519297,-0.195045539327108,0.542959413188536,0.35553368241734
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29111.Ever self-harmed,34319,0.29220835477387,0.313599202323415,-0.322446081780025,0.906862791327764,0.351489369082981
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34306,0.184145591920102,0.183040344935177,-0.174613484152846,0.542904667993049,0.314444786989629
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35725,0.0227801466055407,0.044707709067836,-0.0648469631674179,0.110407256378499,0.610394423993834
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35725,0.00195654990721388,0.0331582894646063,-0.0630336974434144,0.0669467972578421,0.952948849063216
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35725,-0.00778279601228154,0.0404296164088553,-0.0870248441736378,0.0714592521490748,0.847354715595029
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35725,-0.0181810029251071,0.0606558393680821,-0.137066448086548,0.100704442236334,0.764384751708688
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34298,0.152661376495346,0.111903522175616,-0.0666695269688624,0.371992279959553,0.172557503044498
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X29153.Pain or discomfort today,34310,-0.0404042336677758,0.100172777342495,-0.236742877259066,0.155934409923514,0.686710978470945
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29154.Anxiety or depression today,34310,0.0371934518421763,0.127905787291222,-0.21350189124862,0.287888794932972,0.771225354625926
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29166.Frequency of confiding in someone close,34158,0.0709964357890634,0.0990239340840385,-0.123090475015652,0.265083346593779,0.473431066846184
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34295,0.0103272729215535,0.0082216918014808,-0.00578724300934882,0.0264417888524559,0.209136983835134
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34295,-0.0074399726341196,0.00841958362948858,-0.0239423565479172,0.00906241127967801,0.376926338363208
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34295,-0.0130770666438681,0.0104983381846012,-0.0336538094856864,0.0074996761979502,0.212956716633281
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34295,-0.0178098576515844,0.00972551165000789,-0.0368718604855998,0.0012521451824311,0.0671213090610056
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34295,-0.0083110780297498,0.0164051972469018,-0.0404652646336774,0.0238431085741778,0.612448630590817
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34295,0.00130719683501375,0.00796771268311257,-0.0143095200238869,0.0169239136939144,0.869689037862412
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34291,-0.0122283709419618,0.00852954028759381,-0.0289462699056456,0.0044895280217221,0.15173365662538
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34291,0.00859649704034981,0.0131324461650912,-0.017143097443229,0.0343360915239286,0.512754969405782
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34291,0.00364242259501684,0.0191045080328573,-0.0338024131493835,0.0410872583394171,0.848801331947569
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34291,-0.00770126972606132,0.0152658191256743,-0.0376222752123829,0.0222197357602603,0.613947333458213
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34291,-0.028018032010512,0.0248201946176162,-0.0766656134610398,0.0206295494400157,0.259018402222245
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34291,0.0132952733021303,0.0115301172240449,-0.00930375645699768,0.0358943030612583,0.248927145836532
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29171.Frequency of feeling 'in tune' with people,34209,0.0192758219061189,0.123251807212186,-0.222297720229766,0.260849364042004,0.875728898393973
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29172.Freuency of feeling that lacks companionship,34277,0.078114642434668,0.11270903081644,-0.142795057965554,0.299024342834889,0.488300665773072
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29173.Frequency of feeling left out,34244,0.0478782915189295,0.119312457849577,-0.185974125866242,0.281730708904101,0.688227338235633
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29174.Frequency of feeling isolated from others,34271,0.115465449720097,0.122866656526003,-0.125353197070868,0.356284096511062,0.347384225601482
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29175.Tendency to bounce back quickly after hard times,34306,0.228823896091993,0.0988763857382072,0.035026180045107,0.422621612138879,0.0206939149426536
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29176.Ability to make it through stressful events,34306,-0.0526829298884687,0.095623656022562,-0.24010529569269,0.134739435915753,0.58169866093498
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29177.Quick recovery from stressful events,34306,-0.000953703502825104,0.0990776929702336,-0.195145981724483,0.193238574718833,0.992320205583792
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29178.Hard to snap back when something bad happens,34306,-0.0846561457954081,0.0960950504598937,-0.2730024446968,0.103690153105983,0.378379501633125
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29179.Comes through difficult times with little trouble,34306,0.0132554245974509,0.0988315007174992,-0.180454316808848,0.206965166003749,0.893311817765629
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29180.Tendency to take a long time to get over setbacks,34306,-0.0683476216012388,0.0999561914984099,-0.264261756938122,0.127566513735645,0.494147780847306
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29181.General happiness,34283,0.0109419192724565,0.0996015642665632,-0.184277146690007,0.20616098523492,0.91252719797138
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29182.Belief that own life is meaningful,34201,0.0775631017112142,0.100697195864264,-0.119803402182742,0.274929605605171,0.441181571829362
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34554,0.0157921633358472,0.0977525274576586,-0.175802790481164,0.207387117152858,0.871664369204036
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2946.Father's age,30012,-0.00632412325368595,0.0184683981930855,-0.0425221837121335,0.0298739372047616,0.732115702400124
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2966.Age high blood pressure diagnosed,35513,-0.00241760060724137,0.00356332430148292,-0.00940171623814789,0.00456651502366515,0.497500012610565
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30000.White blood cell (leukocyte) count,47995,-0.000896864628612433,0.00204130616560737,-0.00489782471320288,0.00310409545597802,0.660407049548416
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47996,-0.00454023982172437,0.00217884494651485,-0.00881077591689347,-0.000269703726555271,0.0371933904987203
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30020.Haemoglobin concentration,47996,-0.00156391263547282,0.00235759922703582,-0.00618480712046302,0.00305698184951739,0.507114773885886
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30030.Haematocrit percentage,47996,-0.00141116893032049,0.00229100354492615,-0.00590153587837574,0.00307919801773477,0.537927688832811
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30040.Mean corpuscular volume,47996,0.00518029688868615,0.00197903396390744,0.00130139031942756,0.00905920345794474,0.00886243980399557
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47996,0.00447317056479378,0.00198607829230757,0.000580457111870949,0.00836588401771661,0.0243171460968289
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47996,0.000208484683140703,0.0019401657286147,-0.00359424014494411,0.00401120951122552,0.914427462912032
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47996,-0.00167594555811928,0.00199992646352326,-0.00559580142662487,0.0022439103103863,0.402039339131438
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30080.Platelet count,47996,-0.000259200977001933,0.00196485118746377,-0.00411030930443092,0.00359190735042706,0.895049862983598
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30090.Platelet crit,47996,-8.58601102338665e-05,0.00200414557957086,-0.00401398544619275,0.00384226522572502,0.965828532981234
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47996,0.000252560613304529,0.00186477226343108,-0.00340239302302038,0.00390751424962944,0.892267205997055
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30110.Platelet distribution width,47996,0.00143567631012538,0.00194323843138489,-0.002373071015389,0.00524442363563976,0.460033999712035
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30120.Lymphocyte count,47964,0.00166735815269526,0.00191995797060671,-0.00209575946969389,0.00543047577508441,0.38516750082362
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30130.Monocyte count,47964,-0.00224719266527969,0.00196552751841645,-0.00609962660137594,0.00160524127081656,0.25292756942922
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30140.Neutrophill count,47964,-0.00184654261027453,0.00202417906309677,-0.00581393357394419,0.00212084835339513,0.36165267714499
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30150.Eosinophill count,47964,0.000914161505063341,0.00192864543165245,-0.00286598354097547,0.00469430655110215,0.635511495288761
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30160.Basophill count,47964,0.136770690093489,0.0582733437717125,0.0225549363009322,0.250986443886045,0.0189328421152994
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30170.Nucleated red blood cell count,47964,-0.473432728775384,0.297629828538092,-1.05678719271004,0.109921735159276,0.111699274125232
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30180.Lymphocyte percentage,47965,0.00252054148066814,0.00191199057834779,-0.00122696005289352,0.0062680430142298,0.187425574281273
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30190.Monocyte percentage,47965,-0.00142698872000299,0.00194380795733271,-0.00523685231637511,0.00238287487636912,0.462884642296034
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30200.Neutrophill percentage,47965,-0.00227879821945263,0.0019018171518683,-0.0060063598371145,0.00144876339820924,0.230845921791918
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30210.Eosinophill percentage,47965,0.00129211165694594,0.00191768423054929,-0.00246654943493067,0.00505077274882254,0.500454721579738
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30220.Basophill percentage,47965,0.00586388327217315,0.00191605883169311,0.00210840796205466,0.00961935858229165,0.00221362487619681
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30230.Nucleated red blood cell percentage,47964,-0.476860512428388,0.297812652134954,-1.0605733106129,0.106852285756122,0.109347306778673
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30240.Reticulocyte percentage,47649,-0.000183054734647131,0.00207237439810035,-0.00424490855492381,0.00387879908562955,0.92961462377901
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30250.Reticulocyte count,47649,-0.00120507922927559,0.00211195062165985,-0.00534450244772889,0.00293434398917771,0.568277699920039
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30260.Mean reticulocyte volume,47649,0.00228806588288234,0.0019367514519187,-0.00150796696287831,0.00608409872864298,0.237461599669453
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30270.Mean sphered cell volume,47649,0.00331844031536612,0.00196254841112142,-0.00052815457043185,0.0071650352011641,0.0908759809800714
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30280.Immature reticulocyte fraction,47649,-0.00122964402205294,0.00204618656453491,-0.00524016968854137,0.00278088164443549,0.547884508747688
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47649,-6.56233211483429e-05,0.00211185726255044,-0.00420486355574721,0.00407361691345052,0.975211061351473
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30300.High light scatter reticulocyte count,47649,-0.00107382190924282,0.00214080427514904,-0.00526979828853495,0.0031221544700493,0.615956715363296
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30500.Microalbumin in urine,35873,-0.000141425896348599,0.00315087289940062,-0.00631713677917382,0.00603428498647662,0.964200576390296
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47971,0.000128976417976354,0.00212905814115798,-0.00404397753869329,0.004301930374646,0.951695066462941
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30520.Potassium in urine,47941,0.0034114912631538,0.00199424767350077,-0.000497234176907705,0.00732021670321531,0.0871593715529724
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30530.Sodium in urine,47923,-0.000649304050139113,0.0021005852796796,-0.00476645119831113,0.0034678430980329,0.757244139236462
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30600.Albumin,46107,0.00199910534538405,0.00206228616466238,-0.00204297553735422,0.00604118622812231,0.332377619357999
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30610.Alkaline phosphatase,47620,-0.00610302352116137,0.00204619257905181,-0.0101135609761029,-0.00209248606621982,0.00286162689349309
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30620.Alanine aminotransferase,47623,-0.001663014727512,0.00217031414294612,-0.0059168304476864,0.00259080099266241,0.443534220771017
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30630.Apolipoprotein A,45985,0.0011790432564812,0.00227403403361743,-0.00327806344940897,0.00563614996237137,0.604129601583118
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30640.Apolipoprotein B,47540,0.00197799265269255,0.00189484038625366,-0.00173589450436461,0.00569187980974972,0.296553038075185
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30650.Aspartate aminotransferase,47567,-0.0026854061818296,0.00206114125142192,-0.00672524303461657,0.00135443067095736,0.192634303374815
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30660.Direct bilirubin,44938,-0.000149201057823836,0.00219144065029705,-0.00444442473240605,0.00414602261675838,0.945719990206872
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30670.Urea,47613,-0.00260321923925483,0.00203795662391528,-0.00659761422212879,0.00139117574361912,0.201488688934258
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30680.Calcium,46105,-0.000972921031706089,0.00200869304626817,-0.0049099594023917,0.00296411733897952,0.628140040974775
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30690.Cholesterol,47627,0.00172951015427603,0.00191273866785626,-0.00201945763472224,0.00547847794327431,0.365897892422042
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30700.Creatinine,47619,-0.00334133154350599,0.00230220529113441,-0.00785365391412943,0.00117099082711745,0.146696320083696
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30710.C-reactive protein,47570,-0.00298273545507929,0.00215918201926059,-0.00721473221283004,0.00124926130267146,0.167166907795585
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30720.Cystatin C,47633,-0.0043138514216543,0.00224967480066287,-0.00872321403095352,9.55111876449226e-05,0.0551842317200395
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30730.Gamma glutamyltransferase,47621,-0.000953857461870054,0.00219114165299783,-0.00524849510174581,0.0033407801780057,0.663332062945855
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30740.Glucose,46091,0.00368383231674302,0.00205855068996848,-0.000350927035595198,0.00771859166908124,0.073547864143311
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47624,0.00113128239997513,0.00209865846075751,-0.00298208818310959,0.00524465298305985,0.589858682853592
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30760.HDL cholesterol,46098,0.000905233501126384,0.00232971657247415,-0.00366101098092295,0.00547147798317571,0.697606926586268
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30770.IGF-1,47521,0.000218654749074615,0.00200939204798987,-0.00371975366498553,0.00415706316313476,0.913349330639079
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30780.LDL direct,47583,0.00167260411926462,0.00187502168228785,-0.00200243837801956,0.00534764661654881,0.372380370064416
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30790.Lipoprotein A,43889,0.000602605562753704,0.00213175717129029,-0.00357563849297526,0.00478084961848266,0.777425970060057
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30810.Phosphate,46075,0.00241570867187484,0.00214635258599903,-0.00179114239668325,0.00662255974043293,0.26039542116976
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30830.SHBG,45953,0.00168273157812884,0.00248614705851632,-0.00319011665656314,0.00655557981282083,0.49851482619554
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30840.Total bilirubin,47550,0.00106809097579741,0.00209661182914134,-0.00304126820931963,0.00517745016091445,0.610452293274871
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30850.Testosterone,45439,0.000651275068989272,0.00332841113361872,-0.00587241075290341,0.00717496089088196,0.844869770787408
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30860.Total protein,46092,-0.00118875099668985,0.00201035366460326,-0.00512904417931225,0.00275154218593254,0.55431771725757
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30870.Triglycerides,47615,-0.000793570068274696,0.00218498490531018,-0.00507614048268264,0.00348900034613325,0.716465278412111
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30880.Urate,47597,-0.00169262120504701,0.00238155785625675,-0.00636047460331024,0.00297523219321623,0.477266664812865
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30890.Vitamin D,46687,-0.00107398461508885,0.0022212797963165,-0.00542769301586919,0.00327972378569148,0.628748142975279
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3137.Number of measurements made,46432,0.0130611683552442,0.0676731226493617,-0.119578152037505,0.145700488747993,0.846958283055549
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3143.Ankle spacing width,40093,0.00960814082536283,0.00334259037624122,0.00305666368793004,0.0161596179627956,0.00405502688318704
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40093,-0.00268815641435254,0.00260010724056629,-0.00778436660586248,0.00240805377715739,0.301222840264636
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3146.Speed of sound through heel,40093,-0.00355791168823152,0.00249808813265679,-0.00845416442823882,0.00133834105177579,0.15440162573634
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40093,-0.00329705481242063,0.00252813489936368,-0.00825219921517343,0.00165808959033218,0.192211645469949
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3148.Heel bone mineral density (BMD),40083,-0.00330129709271085,0.0025326544712174,-0.00826529985629696,0.00166270567087525,0.192434101070752
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X3526.Mother's age at death,45229,-0.000131442034231229,0.00199280432426718,-0.0040373385097949,0.00377445444133244,0.947411827693307
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X3581.Age at menopause (last menstrual period),37020,-0.00153695891978578,0.00276342144894362,-0.00695326495971527,0.00387934712014371,0.578103912375682
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32219,-0.00361980193677538,0.00419921005880498,-0.0118502536520331,0.00461064977848238,0.388744986779196
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4100.Ankle spacing width (left),35608,0.00211237250940731,0.00453316420669746,-0.00677262933571971,0.0109973743545343,0.641244273554314
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35606,-0.0035443528461803,0.0035437225287483,-0.010490049002527,0.00340134331016636,0.317262179874767
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4103.Speed of sound through heel (left),35608,0.00105343839573141,0.00339146220246631,-0.00559382752110255,0.00770070431256538,0.75610355806487
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35608,-0.000600950293702511,0.00343619500938881,-0.00733589251210458,0.00613399192469956,0.861172926198621
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4105.Heel bone mineral density (BMD) (left),35605,-0.0011566856939336,0.00343267807359029,-0.00788473471817056,0.00557136333030336,0.736155780210449
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35608,-0.000600540130172837,0.00343618101073365,-0.00733545491121079,0.00613437465086511,0.861266158408597
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4119.Ankle spacing width (right),35605,0.00815329517482689,0.00449403293962767,-0.000655009386843351,0.0169615997364971,0.0696861081326037
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35604,-0.00455858847137594,0.00352854827331315,-0.0114745430870697,0.00235736614431782,0.19643276341321
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4122.Speed of sound through heel (right),35605,-0.00220940753752696,0.00337405193747967,-0.00882254933498711,0.00440373425993319,0.512605074220452
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35605,-0.00326573704715815,0.00342020097556808,-0.00996933095927159,0.00343785686495528,0.339695748383281
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4124.Heel bone mineral density (BMD) (right),35601,-0.00348290623268209,0.00341694021228207,-0.010180109048755,0.00321429658339077,0.308096401629011
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35605,-0.00326573922386337,0.0034201906115732,-0.00996931282254684,0.00343783437482011,0.339693963207191
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4194.Pulse rate,35905,-0.00294890277362415,0.00323262804251926,-0.0092848537369619,0.00338704818971361,0.361680016048918
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4195.Pulse wave reflection index,35905,0.000142316307461438,0.00348735003347521,-0.00669288975814998,0.00697752237307285,0.967449140601219
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4196.Pulse wave peak to peak time,35901,-0.000168147487036916,0.00319344741054902,-0.00642730441171299,0.00609100943763916,0.95800923201743
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4198.Position of the pulse wave peak,35905,-0.00139967994156685,0.00339990260328002,-0.00806348904399569,0.00526412916086198,0.680585400333282
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4199.Position of pulse wave notch,35905,-0.00527434795869567,0.00324043911329942,-0.0116256086207625,0.00107691270337119,0.103642971280858
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4200.Position of the shoulder on the pulse waveform,35905,-0.00112481127457127,0.00334641604669491,-0.00768378672609329,0.00543416417695076,0.73678775047739
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4269.Number of triplets attempted (left),35750,-0.0901680429229563,0.252776486141164,-0.585609955759639,0.405273869913726,0.721320000644925
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4270.Volume level set by participant (left),35678,0.0988489059381853,0.0880409878660256,-0.073711430279225,0.271409242155596,0.261580997584459
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4276.Number of triplets attempted (right),35745,0.17979443806504,0.261499439838309,-0.332744464018046,0.692333340148126,0.491759393115791
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4277.Volume level set by participant (right),35670,0.0675958937644466,0.0865812331280605,-0.102103323166552,0.237295110695445,0.434994430122937
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X4288.Time to answer,35908,-0.00113785143486931,0.0038633495703989,-0.00871001659285116,0.00643431372311254,0.768366184264265
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X4290.Duration screen displayed,35908,0.00306131093591703,0.00358645956246304,-0.00396814980651054,0.0100907716783446,0.393371165337294
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X46.Hand grip strength (left),48484,0.00487204942601806,0.0027592199076941,-0.000536021593062382,0.0102801204450985,0.0774562403658632
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X47.Hand grip strength (right),48504,0.00398481972460671,0.00274235709043032,-0.00139020017263673,0.00935983962185014,0.146222299758294
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X48.Waist circumference,48561,-0.00318688666147961,0.00416708241662226,-0.0113543681980592,0.00498059487510003,0.444413968289354
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X4803.Tinnitus,35821,0.0822959088520207,0.0984066501722062,-0.110581125485503,0.275172943189545,0.40302530791271
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X4825.Noisy workplace,35895,0.184204801076961,0.109583707125704,-0.0305792648894182,0.39898886704334,0.0928191229098182
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X4836.Loud music exposure frequency,35853,-0.0633995652363237,0.188022396130874,-0.431923461652837,0.305124331180189,0.735983128946172
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X49.Hip circumference,48556,-0.000302141175584119,0.00338398381410011,-0.00693474945122034,0.0063304671000521,0.928855826063229
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X50.Standing height,48545,0.00132084669247086,0.00268235797991266,-0.00393657494815796,0.00657826833309968,0.622428056421471
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X5057.Number of older siblings,34875,0.0145464881138272,0.0942683848479016,-0.17021954618806,0.199312522415714,0.877371350159556
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X51.Seated height,48471,0.00320637131019633,0.00251630164279641,-0.00172557990968463,0.00813832253007729,0.202593860200917
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5181.Ever had eye surgery,33720,-0.246053653054016,0.196986219372424,-0.632146643023967,0.140039336915934,0.211696530408197
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5186.Duration visual-acuity screen displayed (right),33707,0.00310295590483757,0.00395644144406677,-0.0046516693255333,0.0108575811352085,0.432917289551088
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5188.Duration visual-acuity screen displayed (left),33706,0.0039793472369807,0.00408720482534661,-0.00403157422069865,0.01199026869466,0.330301956068362
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5190.Duration at which refractometer first shown (right),33647,0.00326960533714223,0.00419388751954998,-0.00495041420117573,0.0114896248754602,0.435660680239797
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5193.Duration at which refractometer first shown (left),33645,0.00093839947336265,0.00424052264742042,-0.00737302491558138,0.00924982386230668,0.824874176531583
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5199.logMAR, initial (right)",33692,-0.0107998731820728,0.108174780711494,-0.222822443376602,0.201222697012456,0.920477980678197
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5200.Final number of letters displayed (right),33692,0.795418467277802,0.711579556302864,-0.599277463075812,2.19011439763142,0.26370323863385
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5201.logMAR, final (right)",33640,0.00194346178126196,0.00441974113536168,-0.00671923084404692,0.0106061544065709,0.660159123134735
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5202.Number of rounds to result (right),33692,-0.0511136340862076,0.0990828562675753,-0.245316032370655,0.14308876419824,0.605972310505249
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5206.logMAR, initial (left)",33687,0.0392220969018893,0.112455731186356,-0.181191136223368,0.259635330027146,0.72727224779773
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5207.Final number of letters displayed (left),33687,0.0560866323938847,0.615136647798795,-1.14958119729175,1.26175446207952,0.927355605397202
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5208.logMAR, final (left)",33636,-0.00430568755120129,0.00434565875762801,-0.0128231787161522,0.0042118036137496,0.321836221255738
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5209.Number of rounds to result (left),33685,0.0972798248578429,0.100175294282253,-0.0990637519353724,0.293623401651058,0.331552914647685
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33481,-0.000970379187697297,0.00401677716377664,-0.00884326242869952,0.00690250405330492,0.809115986457532
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33481,-0.00257140765030715,0.00404260317608988,-0.0104949098754433,0.005352094574829,0.524760070570404
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5256.Corneal hysteresis (right),33481,-0.00232941656314603,0.00404668657899277,-0.0102609222579719,0.0056020891316798,0.56489177538403
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5257.Corneal resistance factor (right),33481,-0.00287176331296586,0.00407706851248203,-0.0108628175974306,0.00511929097149891,0.481240862756433
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33473,-0.00285960497441321,0.00400364535310491,-0.0107067498664988,0.00498753991767241,0.475111365520748
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33473,-0.00473052156115269,0.00402057000652675,-0.0126108387739451,0.00314979565163974,0.239428701295954
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5264.Corneal hysteresis (left),33473,-0.00256865816571857,0.00408676187621666,-0.0105787114431032,0.00544139511166608,0.529689430086447
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5265.Corneal resistance factor (left),33473,-0.00511509519502085,0.00409284034105587,-0.0131370622634903,0.00290687187344865,0.211453167024276
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33774,1.12612487184454,0.343008687312989,0.453827844711083,1.798421898978,0.00103450354937765
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48516,0.00943489404549177,0.0101982110780716,-0.0105535996675286,0.0294233877585121,0.354898469364767
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48516,-0.00741397960463432,0.010826492416996,-0.0286339047419464,0.0138059455326778,0.493478489581807
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48516,0.0453157629508802,0.0282516251845734,-0.0100574224108838,0.100688948312644,0.108729178319135
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48516,-0.00380426850561429,0.00437800073524875,-0.0123851499467018,0.00477661293547326,0.38488467725374
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48516,0.00115608356412216,0.0041245915983102,-0.00692811596856584,0.00924028309681015,0.779257690944753
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",36788,-0.00143444953704084,0.00597429998561273,-0.0131440775088418,0.0102751784347601,0.810256605436001
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",36788,-0.0183251678534821,0.0127081255155991,-0.0432330938640564,0.00658275815709217,0.149342482337683
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",36788,-0.00321518988930305,0.0154496804627093,-0.0334965635962133,0.0270661838176072,0.835150838818488
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",36788,0.00841746877260914,0.00851100453418903,-0.00826410011440136,0.0250990376596196,0.322689749104399
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48575,-0.00316177000918492,0.00845421095776002,-0.0197320234863946,0.0134084834680247,0.708417637764475
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48575,-0.00316177000918492,0.00845421095776002,-0.0197320234863946,0.0134084834680247,0.708417637764475
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48575,0.00848621453901942,0.00683427183660581,-0.00490895826072797,0.0218813873387668,0.21435693920597
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48575,-0.00504589948655393,0.0116456072329345,-0.0278712896631056,0.0177794906899977,0.664810525367265
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48575,-0.0507170831650047,0.0295584775430106,-0.108651699149305,0.007217532819296,0.0862106259978635
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48575,-0.00769685813575103,0.0193734454798766,-0.0456688112763092,0.0302750950048071,0.691158681547271
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48575,0.0319546256326899,0.0310093214097048,-0.0288236443303315,0.0927328955957113,0.302795475485515
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48516,-0.00629356530877693,0.00628837031300884,-0.0186187711222743,0.0060316405047204,0.316923408903194
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48516,0.00343274174645471,0.0105767963530138,-0.0172977791054524,0.0241632625983618,0.745522146989278
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48516,-0.00183855747208857,0.00626516607846007,-0.0141182829858703,0.0104411680416932,0.769175937214036
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48516,0.00941986899684519,0.00884178440574165,-0.00791002843840845,0.0267497664320988,0.286716869730345
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48516,0.0106428128823026,0.0107260374008469,-0.0103802204233574,0.0316658461879626,0.321092456233432
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48516,0.000574610152636698,0.00423245791321293,-0.00772100735726064,0.00887022766253404,0.892010248763388
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37211,0.00718058084572338,0.0097745146993164,-0.0119774679649368,0.0263386296563835,0.462590766553768
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37211,0.00854716568475193,0.00837034974295544,-0.00785871981144073,0.0249530511809446,0.307226467433598
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37211,0.00764550284191362,0.0120254234515248,-0.0159243271230749,0.0312153328069021,0.524939104587912
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37211,-0.00710246114769863,0.00940160465137759,-0.0255296062643987,0.0113246839690014,0.450000009353401
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48506,-0.0319742583635851,0.0144075210542079,-0.0602129996298327,-0.00373551709733754,0.0264795624243855
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48506,0.0314888511330734,0.0229737363071523,-0.013539672028945,0.0765173742950918,0.170501383231294
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48506,0.000729567523340833,0.0339553234403119,-0.0658228664196705,0.0672820014663522,0.982858112338387
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48506,0.0226482465359766,0.0376842631426554,-0.051212909223628,0.0965094022955812,0.547846962377197
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48506,-0.00210241324009158,0.0121025972309749,-0.0258235038128023,0.0216186773326192,0.862090583312357
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48506,0.00265729410551748,0.0166700615191118,-0.0300160264719417,0.0353306146829767,0.873351327467754
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48506,0.00441129248479214,0.00875131823966366,-0.0127412912649486,0.0215638762345329,0.614216693380375
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34930,0.0132893790090707,0.0119571769639344,-0.0101466878402408,0.0367254458583821,0.266436586733897
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34930,-0.000975826995743481,0.0124147942036516,-0.0253088236349005,0.0233571696434136,0.937351980618963
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34930,-0.0209029092980565,0.0177358595714525,-0.0556651940581034,0.0138593754619904,0.238619290983754
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34930,0.0082905509297901,0.00729329443412309,-0.00600430616109115,0.0225854080206713,0.255696117385574
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38670,-0.00371086613068791,0.00556360522402202,-0.0146155323697711,0.00719380010839524,0.504795096205253
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38670,-0.00953611480218143,0.00654189387407392,-0.0223582267953663,0.00328599719100346,0.144956554856159
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38670,0.0105658364330618,0.00544840950537638,-0.000113046197475927,0.0212447190635995,0.0525003634902789
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38670,0.0136185235641572,0.0125453645602251,-0.010970390973884,0.0382074381021984,0.277709166037443
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38670,0.0165425795346635,0.00698437685537288,0.00285320089813263,0.0302319581711943,0.017879752190543
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38670,0.000279613154248907,0.0100852568196314,-0.0194874902122287,0.0200467165207265,0.977882114823437
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48516,-0.00318836796401919,0.011739786489765,-0.0261983494839585,0.0198216135559201,0.785942853516483
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48516,-0.00556752643524795,0.00890270927065138,-0.0230168366057246,0.0118817837352287,0.531732748135468
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48516,-0.0141289795160308,0.0237617473052319,-0.0607020042342852,0.0324440452022236,0.552110960905961
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48516,-0.0016720302912958,0.00832598565122286,-0.0179909621676926,0.014646901585101,0.840840887794897
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48516,0.00511381271024717,0.00964685481482289,-0.0137940227268057,0.0240216481473,0.596047614385373
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48516,-0.027682833347365,0.0117847204482773,-0.0507808854259885,-0.00458478126874145,0.0188316696781086
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48516,-0.00408802169886276,0.0039528500159859,-0.0118356077301951,0.0036595643324696,0.301057484424026
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33965,-0.000660774402014216,0.0100581372682839,-0.0203747234478507,0.0190531746438223,0.947623003512567
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33965,-0.00446076769097407,0.0125563625855787,-0.0290712383587082,0.0201497029767601,0.72241085872691
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33965,0.000838468809829599,0.00868912986765707,-0.0161922257307783,0.0178691633504375,0.923130471142121
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33965,0.00336202911279722,0.00814528962040472,-0.012602738543196,0.0193267967687905,0.679802859740484
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48593,-0.000442355532342423,0.00524697534644048,-0.0107264272113658,0.00984171614668092,0.932813401558418
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48593,0.00842682685285761,0.0147172749597591,-0.0204190320682702,0.0372726857739854,0.566935300635477
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48593,-0.00154121969695412,0.00440070542233769,-0.010166602324736,0.00708416293082775,0.72617660870245
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48593,0.00509570282248619,0.00423335774968972,-0.00320167836690567,0.013393084011878,0.228719317799262
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48593,0.0125291752670385,0.00721790795673823,-0.00161792432816839,0.0266762748622455,0.0826069801667605
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48593,-0.00514573947984279,0.00539660341363091,-0.0157230821705594,0.0054316032108738,0.340341345571693
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48593,-0.00261840888242616,0.00441500582374574,-0.0112718202969678,0.00603500253211549,0.553141011418402
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48593,-0.00806122510927595,0.0136374384051929,-0.034790604383454,0.0186681541649021,0.554453661430403
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42999,-0.0061245434686426,0.00464430011023016,-0.0152273716846937,0.00297828474740851,0.187283747455129
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42999,0.00543804512039671,0.00483077331882373,-0.0040302705844978,0.0149063608252912,0.260308272213245
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42999,-0.00188384090949728,0.00510743944940545,-0.011894422230332,0.00812674041133741,0.712250755144511
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42999,0.00168906868661671,0.006923635003944,-0.0118812559211135,0.015259393294347,0.807267808291349
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42999,-0.0040242806633859,0.00465714614941034,-0.0131522871162302,0.00510372578945836,0.38754317489859
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48409,-0.00936038629366255,0.00462988490168645,-0.018434960700968,-0.000285811886357118,0.0432178824509263
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48409,0.00319341234188268,0.00376548166851365,-0.00418693172840408,0.0105737564121694,0.396406549101866
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48409,0.00437587800088865,0.00390028337535414,-0.00326867741480546,0.0120204334165828,0.26190261785425
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48409,0.0130271914142804,0.00851429789578655,-0.00366083246146121,0.0297152152900221,0.126024014727575
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48424,0.00370770166454252,0.00419730594164831,-0.00451901798108817,0.0119344213101732,0.377056764750294
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48424,0.00378787727020017,0.00825712415759381,-0.0123960860786837,0.019971840619084,0.646425710915411
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48516,-0.00624465410647587,0.00381733146241523,-0.0137266237728097,0.00123731555985799,0.101883300030096
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48516,0.00406744671847736,0.0043603345192729,-0.00447880893929752,0.0126137023762522,0.350919894359066
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48516,0.000748226031294535,0.00660879463939161,-0.012205011461913,0.0137014635245021,0.909859918970734
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48516,-0.013410868464987,0.00919444243302837,-0.0314319756337226,0.00461023870374862,0.144695839279339
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48516,-0.00429464293774105,0.0116922434519503,-0.0272114401035636,0.0186221542280815,0.713394051351415
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48516,-0.0127326876749184,0.0107901613577269,-0.0338814039360631,0.00841602858622637,0.238003785050818
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40093,-0.00330038210666505,0.00252812082447445,-0.00825549892263498,0.00165473470930487,0.191760922128874
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X864.Number of days or week walked 10+ minutes,48119,0.00402077993979064,0.0523353665437529,-0.098556538485965,0.106598098365546,0.938761820545751
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X874.Duration of walks,45544,-0.00319251528059261,0.00209463833914151,-0.00729800642530997,0.000912975864124758,0.127493893905724
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47311,-0.0565115261939306,0.050820345460329,-0.156119403296176,0.0430963509083144,0.26615881573259
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X894.Duration of moderate activity,43247,-0.0772901757269045,0.0620670456492093,-0.198941585199355,0.0443612337455458,0.21305360494327
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X90087.No-wear time bias adjusted average acceleration,32797,0.00361827724704204,0.00496064611490544,-0.00610458913817262,0.0133411436322567,0.465806652920401
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47246,-0.0577859719575573,0.0526740682480483,-0.161027145723732,0.0454552018086173,0.272635125128777
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X914.Duration of vigorous activity,38633,0.00100345644798653,0.0025288442792298,-0.00395307833930387,0.00595999123527694,0.691520702673815
